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ABSTRACT
Early stages of high blood pressure, such as elevated blood pressure or stage 1
hypertension, have shown to increase cardiovascular mortality. Exercise is recommended for the
prevention and treatment of high blood pressure; however, most clinical evidence is based on
traditional types of exercise that have relatively high dropout rates. Therefore, the purpose of this
study was to evaluate the effects of boxing training, a nontraditional exercise modality, on
clinical and vascular outcomes and its relation to blood flow patterns in individuals with elevated
blood pressure or stage 1 hypertension. To achieve these goals, two experiments were designed.
The first one, a randomized controlled trial, evaluated the effects of boxing training on brachial
blood pressure, central blood pressure, arterial stiffness, cardiorespiratory fitness, cardiac
adaptations, body composition, lipid profile, quality of life, vascular adaptations, nitric oxide
bioavailability, inflammation, and oxidative stress in individuals with elevated blood pressure or
stage 1 hypertension. The main findings were that 6 weeks of boxing training, with a polarized
intensity regime, in individuals with elevated blood pressure or stage 1 hypertension improved
clinical outcomes, such as peripheral and central blood pressure, resting heart rate, myocardial
wall thickness, VO2max, ventilatory and lactate thresholds, and quality of life, and vascular
outcomes, such as conduit artery endothelial function, resistance vessels structure and
endothelial function, and carotid artery structure. All these changes were linked to an increased
nitric oxide bioavailability and a reduction in inflammation. The second one, a cross-sectional
study, confirmed that endothelial shear stress in the common carotid artery increased during
boxing training in individuals with elevated blood pressure or stage 1 hypertension.
Altogether, we proposed that boxing training is a suitable alternative for the management
of elevated blood pressure and stage 1 hypertension.
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CHAPTER 1: INTRODUCTION, STATEMENT OF PURPOSE, AND SPECIFIC AIMS
1.1. Introduction
1.1.1. Introduction and Significance
Cardiovascular diseases (CVD) such as coronary artery disease, heart failure, peripheral
artery disease, and stroke are the leading cause of death in the US and worldwide. CVD are
responsible for 17.3 million deaths, which account a third of all global causes of death, which
accounts [1]. Additionally, CVD are the second most common cause of disability in the US, with
a 16.8% of total disability-adjusted life-years (DALYs) [2,3], and the first cause of global
disability, with an 11.8% of total DALYs [4].
Nearly 92.1 million US adults suffer from at least one type of CVD, which represents
36.6% of the entire US adult population. According to the projections of the American Heart
Association (AHA), a 7.3% growth is expected by 2030. The total cost of CVD is approximately
$316.1 billion; according to the projections for 2030, direct and indirect costs will reach $818
billion and $276 billion, respectively [1].
Several risk factors have been associated to CVD, such as high blood pressure, obesity
dyslipidemia, impaired fasting glucose, sedentary behavior, and physical inactivity [5]. Among
all these cardiovascular risk factors, high blood pressure is the most prevalent [6]. Taking into
consideration the current ACC/AHA classification, approximately 46% of the total US adult
population (116 million) are diagnosed with hypertension [7]. Apart from being a risk factor for
the development of CVD, high blood pressure affects several organs (e.g. chronic kidney
disease, retinopathy, and cognitive impairment) [8]. By itself, high blood pressure accounts for
34.1% of all deaths in US adults, with the estimated total cost of medical treatment for high
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blood pressure in the country at $52.1 billion. If no action is taken, the total cost of high blood
pressure treatment and management within the US will be around $200 billion by 2030 [1].
Elevated blood pressure or stage 1 hypertension are categories of high blood pressure
formerly known as prehypertension. The prevalence of both categories ranges from 22% to 38%.
The main feature of relevance for these categories is the risk of progression to more severe high
blood pressure stages, which have been estimated to be two- to three-fold higher in comparison
to normotensive adults [9-13]. Moreover, compared to subjects with optimal blood pressure,
those with elevated blood pressure or stage 1 hypertension have an estimated increased risk of
50%, 71%, 55%, and 66% for coronary artery disease, stroke, CVD-related morbidity and CVDrelated mortality, respectively [14-16].
Individuals with elevated blood pressure or stage 1 hypertension without an estimated 10year risk of CVD of ≥10%, as calculated by the ACC/AHA Pooled Cohort Equations, are not
candidates for drug treatment. In turn, management strategies for this population primarily
include lifestyle modifications, such as the incorporation of an exercise training program
[7,9,17]. Current medical guidelines have established that exercise is a cornerstone in high blood
pressure prevention and treatment and its effectiveness is comparable to drug treatment [7,18].
Indeed, for every dollar invested in strategies to incorporate physical activity as a preventive
cardiovascular tool, there is a return of approximately three to six dollars in terms of healthcare
costs [1,19]. However, the optimal exercise prescription dose for high blood pressure and the
mechanisms behind the health benefits of exercise are have not yet fully been clarified [20,21].
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1.1.2. Background
High blood pressure is an operational definition that relates in a log-linear manner the
levels of brachial blood pressure to organ damage, morbidity, and mortality [7]. Several
pathological features are involved and interconnected in the development of high blood pressure,
such as endothelial dysfunction, oxidative stress, inflammation, autonomic dysfunction, an
overreactive renin-angiotensin-aldosterone pathway, and arterial stiffness [8]. Endothelial
dysfunction appears to have a central role in the progression to high blood pressure according to
the Mosaic Theory, mainly by affecting the ability of the vessels to maintain homeostasis [22].
Endothelial dysfunction can be identified by one or more of the following characteristics: (1) a
decline in nitric oxide (NO) bioavailability and subsequent impaired vasodilation, (2)
upregulation of adhesion molecules and inflammatory genes, (3) oxidant stress exacerbation, and
(4) increased permeability of the endothelial barrier [23]. Additionally, the decreased NO
bioavailability produces a cascade of events including oxidation of low-density lipoprotein
cholesterol (LDL-C), leukocyte recruitment, and foam cell formation which becomes the basis of
atherosclerotic plaque formation [24,25]. Meanwhile, arterial stiffness directly impacts blood
pressure by affecting afterload and arterial-ventricular coupling [26,27].
Exercise training has shown to be beneficial to prevent or treat CVD and to improve
cardiovascular risk factors. Specifically, exercise training is a recommendation class IA for
individuals with individuals with elevated blood pressure or stage 1 hypertension [7]. A class IA
recommendation is the strongest recommendation given for a treatment that is based on multiple
randomized controlled trials or meta-analyses [6]. Meta-analyses have described that exercise
significantly improves brachial blood pressure [18,28,29], central blood pressure [30],
cardiorespiratory fitness [31], arterial stiffness [32], the lipid profile, and body composition [31]
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in individuals with high blood pressure. Additionally, exercise training can target cellular
pathways involved with high blood pressure and produce favorable adaptations in the structure
and function of the heart and vessels [21,33]. The cardiovascular health benefits of exercise go
beyond the reduction of cardiovascular risk factors [20]. Endothelial shear stress has been
recognized as a mechanism that modulates endothelial gene expression through
mechanotransduction [34]. Exercise-induced shear stress has been related to favorable
cardiovascular adaptations but the evidence related to this topic is based on limited exercise
modalities (e.g. running, cycling, or resistance training) [21].
Even though the beneficial effects of exercise on health are well known, only 21.6% of
the US adult population cover the minimal weekly recommendations [1]. Moreover, CVD
patients are not that committed to incorporate exercise as part of their cardiac rehabilitation
programs as dropout rates from cardiac rehabilitation programs has been estimated as high as
80% [35-37]. Multiple factors affect the decision to adhere an exercise program, such as
personality, personal preferences, and organizational characteristics [38-42]. The incorporation
of more exercise alternatives (e.g. nontraditional modalities) to traditional physical activity
programs (e.g. walking, running, cycling, and resistance training) might attract more people and
increase the retention [35,43,44]. However, before a nontraditional modality of exercise can be
recommended for health-related purposes, it should be supported by a solid scientific evidence
[45].
Boxing training is a type of exercise that involves high cardiovascular demands, highimpact punching, and coordinated movements in an enjoyable environment [46-48]. Previously,
boxing training has shown to have excellent motor outcomes in stroke [49] and Parkinson’s
disease patients[50,51]. Nonetheless, research regarding the effects of boxing training on
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cardiovascular health is scarce [52,53]. To date, no randomized controlled trial employing
boxing training as an intervention has been executed in individuals with high blood pressure.

1.2. Statement of Purpose
The purpose of this dissertation was to describe the effects of boxing training on
cardiovascular risk and vascular health and its relationship with blood flow in individuals with
elevated blood pressure or stage 1 hypertension. To achieve these goals, two experimental
designs were applied. First, a randomized controlled trial to evaluate the effects of boxing
training on cardiovascular risk and vascular health in individuals with elevated blood pressure or
stage 1 hypertension were employed. Second, in a cross-sectional study we characterized in vivo
common carotid artery blood flow patterns in individuals with elevated blood pressure or stage 1
hypertension during boxing drills.

1.3. Specific Aims and Hypotheses
1.3.1. Experiment 1
Specific Aim 1. To determine whether boxing training reduces cardiovascular risk in individuals
with elevated blood pressure or stage 1 hypertension.
Hypothesis 1. Boxing training, 3 days per week for 6 weeks will reduce cardiovascular risk in
individuals with elevated blood pressure or stage 1 hypertension.
To asses cardiovascular risk factors, the following clinical outcomes will be evaluated:
-

Brachial Blood Pressure

-

Central Blood Pressure

-

Arterial Stiffness
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-

Cardiorespiratory Fitness

-

Structural Cardiac Adaptations

-

Body Composition

-

Lipid Profile

-

Quality of Life

Specific Aim 2. To determine whether boxing training will improve vascular health in
individuals with elevated blood pressure or stage 1 hypertension.
Hypothesis 2. Boxing training 3 days per week for 6 weeks will improve vascular health in
individuals with elevated blood pressure or stage 1 hypertension.
To asses vascular health, the following variables will be evaluated:
-

Endothelial Function and Structure of Conduit Arteries

-

Endothelial Function and Structure of Resistance Vessels

-

Nitric Oxide Bioavailability

-

Inflammation

-

Oxidative Stress

1.3.2. Experiment 2
Specific Aim 3. To characterize blood flow in the carotid artery during boxing training activities
in individuals with elevated blood pressure or stage 1 hypertension.
Hypothesis 3. Anterograde endothelial shear stress will be turbulent and will increase during
boxing training activities in comparison to resting conditions.
The following blood flow characteristics will be analyzed:

6

-

Direction

-

Endothelial Shear Stress magnitude

-

Patterns (presence of turbulence)
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CHAPTER 2: LITERATURE REVIEW
2.1. The Cardiovascular System
The human cardiovascular system is composed of the heart, the vasculature, and the
blood. The main functions of this organ system are to: (1) coordinate the transport and delivery
of respiratory gases, nutrients, waste products, and other chemical messengers, (2) maintain
homeostasis (e.g., liquids, pH, temperature, blood pressure, etc.), and (3) protect the body from
hemorrhage and infections. This system can be functionally divided into two circuits: the
systemic left-circulation and the pulmonary right-circulation. In the systemic circulation, the left
atrium receives oxygenated blood from the pulmonary veins, then the blood accesses the left
ventricle where it is ejected into the aorta to reach organs, while deoxygenated blood returns to
the heart. In the pulmonary circulation, the deoxygenated blood in the right atrium travels to the
right ventricle and it is pumped to the lungs for gas exchange and the oxygenated blood returns
to the heart [54].
The heart is a hollow, muscular, pulsatile blood pump connected to the vascular tree. This
organ can generate and control its own pace through a pacemaker, localized in the right atrium
(the sinoatrial node), and a conduction system (the atrioventricular node, bundle of his, and
Purkinje fibers). Additionally, there is an external control provided by the autonomic nervous
system (sympathetic and parasympathetic) and the endocrine system (e.g. catecholamines) [55].
A blood vessel is a tube-like structure whose wall is generally comprised of three layers:
the intima, the media, and the adventitia. The intima is the innermost layer composed of a
monolayer of endothelial cells, connective tissue located at the subendothelial space, and an elastic
internal membrane. The media is enclosed by the internal and external elastic membranes, contains
smooth muscle cells and extracellular matrix (e.g. elastin and collagen) and provides the contractile
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and elastic properties of the vessels. The adventitia is the outer layer composed of fibroblasts,
connective tissue, perivascular nerves, and the vasa vasorum [56]. Blood vessels can be classified
based on their structure and function in elastic arteries, muscular arteries, resistance vessels,
exchange vessels, and capacitance vessels. Elastic or central arteries (e.g. aorta) are the largest of
all vessels and their great distensibility is a key feature to maintain blood flow during diastole.
Muscular or conduit arteries (e.g., brachial, carotid, brachial, and popliteal) are medium-sized
vessels that direct blood towards smaller branches and constantly adapt their diameters by smooth
muscle relaxation or contraction. Resistance vessels (e.g. terminal arteries and arterioles) are the
central governor of vascular peripheral resistance. Exchange vessels (e.g. capillaries) are the
smallest vessels and are the site of gas and metabolite exchange. Finally, capacitance vessels (e.g.
venules and veins) contain most of the blood under resting conditions and can rapidly
accommodate changes in blood volume according to metabolic requirements. The size,
composition, and main function of each vessel are depicted in Table 1.
Table 1. Blood vessels structure and function
Diameter Wall thickness
(mm)
(mm)
Elastic arteries
15
1
Muscular arteries
5
1
Arterioles
0.03
0.006
Capillaries
0.009
0.0005
Venules
0.02
0.001
Veins
5
0.5
Note. Adapted from Smith and Fernhall [54].

Endothelial
cells (%)
5
5
10
95
20
10

Elastic
tissue (%)
60
13
10
0
0
5

Smooth
muscle (%)
25
65
60
0
20
30

Fibrous
tissue (%)
20
20
20
5
60
60

Main Function
Pulse dampener
Distribution
Resistance
Gas exchange
Capacitance
Blood return

The blood is a body fluid that circulates throughout the body and is composed by blood
cells (e.g., erythrocytes, leukocytes, and thrombocytes) and plasma. Erythrocytes transport oxygen
from the lungs to capillaries, leukocytes modulate the immune system and inflammation, and
thrombocytes initiate blood clot formation. Plasma is the fluid portion in which blood cells are
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suspended and contains water, proteins, signaling molecules, cell-derived vesicles, nutrients,
electrolytes, oxygen, dioxide oxygen, and hormones [54].

2.2. Basic Hemodynamic Concepts
2.2.1. Preload
Preload comprises all the factors that contribute to passive ventricular wall stress at enddiastole and can be expressed according to LaPlace’s Law, T=

⁄2 for thin-walled spheres,

where T is tension, P is chamber pressure, and R is radius. For thick-walled spheres like the left
ventricle, it can be expressed as σ=

⁄2 , where σ is wall stress and w is wall thickness. The

factors that determine end-diastolic radius are the compliance of the ventricle and pericardium.
End-diastolic filling pressure is dependent on total blood volume, blood volume distribution,
atrial contraction, venous compliance, total peripheral resistance, and venous return. Finally,
myocardial wall thickness relies on the state of the individual, for example, long-term high blood
pressure is associated with left ventricular hypertrophy (LVH). End-diastolic left ventricular
pressure and volume are surrogate measurements employed in clinical practice to estimate
preload [57].

2.2.2. Afterload
Afterload is the force against which the heart has to contract to eject the blood. Other
definitions include the stress that the left ventricle experiences when it contracts against the enddiastolic volume or as arterial input impedance. Total peripheral resistance and arterial
compliance are main features of afterload. The arterioles are recognized as the site that
determines peripheral resistance which in turn are controlled by the autonomic nervous system
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(sympathetic/parasympathetic balance) and local mediators like NO. Arterial compliance refers
to the ability of the vessel to expand and contract passively with changes in pressure and is an
index of elasticity. The elastic component of the vascular wall is affected by age and pathological
conditions like high blood pressure, which is translated into stiffer arteries and a long-term
afterload mismatch that can induce LVH, among other complications [58].

2.2.3. Contractility
Contractility, also known as inotropy, is the inherant capacity of the cardiac muscle to
contract independently of preload and afterload and is an expression of the cellular mechanisms
involved with muscle contraction (e.g. excitation-contraction coupling, sarcomere shortening and
subsequent relaxation). From a clinical standpoint, contractility is determined by a change in
work (e.g. left ventricular change in pressure per time, dP/dt) at a fixed end-diastolic volume and
aortic pressure. Ejection fraction (EF) measured by echocardiography and dP/dtmax measured
during cardiac catheterization are indexes of contractility. EF less than 55% and dP/dtmax less
than 1500 mmHg/s are considered as markers of depressed myocardial contractility [59].

2.2.4. Stroke Volume
Stroke volume is the amount of blood ejected by the heart in each beat and is the
difference between end-diastolic volume and end-systolic volume. Stroke volume is affected by
filling time (e.g. raise in stroke volume when duration of diastole is longer), the Frank-Starling
mechanism (e.g. increased venous return produces stretching of sarcomeres that its translated
into an increase in contractility because more myosin heads are in contact with actin’s active
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sites), sympathetic activation and release of catecholamines that increase contractility, and the
vasomotor tone of blood vessels. The normal stroke volume range is ~50-120 ml at rest [54].

2.2.5. Cardiac Output
Cardiac output represents the amount of blood ejected by the ventricle per minute and is
the product between heart rate and stroke volume. Cardiac output is constantly adjusted to
maintain metabolic demands. On average, cardiac output is ~5 L/min at rest and during exercise
this value can increase up to ~20-25 L/min [60].

2.2.6. Blood Pressure
Blood pressure is the hydrostatic force exerted by the blood on the wall of a vessel or a
chamber of the heart. Systolic blood pressure (SBP) is the pressure generated by the blood on the
wall of the vessel during the ventricular contraction. Diastolic blood pressure (DBP) is produced
during ventricular relaxation. The difference between SBP and DBP is known as pulse pressure
(PP). In a simplistic model represented by Ohm’s Law, mean blood pressure can be expressed as
the product between stroke volume, heart rate, and systemic vascular resistance. Blood pressure
is determined by the interaction among many cardiovascular (e.g. cardiac output), renal (e.g. the
renin-angiotensin-aldosterone system regulating sodium absorption and vasoconstriction),
nervous (e.g. sympathetic/parasympathetic balance regulating vascular tone), and endocrine (e.g.
catecholamines) factors and the vascular compliance [61].
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2.2.7. Pulse Waves and Wave Reflections
Elastic central arteries, such as the aorta, are stretched during systole to accommodate the
blood coming from the left ventricle. Due to the viscoelastic properties of elastic arteries, their
wall recoils to maintain blood flow during diastole. In addition to this damping effect, a pressure
wave is generated at the wall and then is transmitted through the arterial tree. The speed of
propagation of pulse waves, also known as pulse wave velocity (PWV), depends on the
characteristics of the vessel. For example, PWV is slower in elastic arteries in comparison to
resistance vessels and is faster in the presence of arterial stiffness. Further, a portion of the
transmitted forward pressure wave is reflected toward the ventricle at branches or at sites with
more resistance (e.g. arterioles) and merges with a secondary forward pressure wave.
Consequently, wave reflection amplifies SBP and the amount of amplification can be measured
through pulse wave analysis (PWA) by the augmentation index (AIx). The AIx is the ratio
between the augmented pressure and the pulse pressure. If the reflection wave overlays the
forward wave at diastole it will favor coronary blood flow. Conversely, if the reflected wave is
fast enough to overlay a forward wave during systole, it will increase afterload [54,58].

2.2.8. Blood Flow and Blood Flow Patterns
Blood flow refers to the movement of blood through a vessel or the heart and it is expressed
in terms of volume as a function of time. Blood travels due to differences in pressure, from an
arterial high-pressure end to a venous low-pressure end. The amount of blood flow is directly
related to pressure differences and inversely related to the peripheral vascular resistance. The main
variables that affect blood flow are cardiac output (e.g. an increase in stroke volume or heart rate
raise blood flow), blood volume (e.g. hypovolemia decrease blood flow), blood viscosity (e.g.
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polycythemia increases viscosity and produces resistance to the flow), compliance (e.g. arterial
stiffness increases the resistance to blood flow), diameter (e.g. vasodilation increases blood flow),
and length (e.g. larger vessels generate more resistance) of the vessel.
The cardiovascular system has two types of mechanisms to adjust blood flow. The first is
the intrinsic control generated by metabolic regulation (e.g. chemoreceptors that sense the
concentrations of oxygen, carbon, dioxide, adenosine, hydrogen, and potassium ions to adjust the
diameter of the artery according to organ or tissue necessities), myogenic response (e.g. an increase
in blood flow induce a vasoconstriction), and endothelial shear stress. The second is the extrinsic
control provided by the autonomic nervous system (e.g. an increase in sympathetic activity
produces vasoconstriction and blood flow reduction in most vessels), the endocrine system (e.g.
catecholamines bind to α-adrenergic receptors of arterioles to enhance vascular resistance and
reduction of blood flow), and the renin-angiotensin-aldosterone system (e.g. angiotensin II acts as
a vasoconstrictor) [54].
The endothelium of arteries is constantly interacting with pulsatile blood flow. Blood
flow intrinsically regulates vascular function and structure through cellular mechanotransduction
pathways [62]. This control is dependent on blood flow singularities; specifically, its magnitude,
directionality, and type [63,64]. Blood flow magnitude, also known as endothelial shear stress
(ESS), can be defined in terms of the amplitude of the tangential force produced by the friction
of the flowing blood on the endothelial apical surface and it can be categorized as low-ESS (<10
dynes/cm2) or high-ESS (≥10 dynes/cm2). Directionality can be described as anterograde if blood
flows downstream, retrograde if blood flows upstream, or oscillatory if the flow is bidirectional
[64]. Finally, blood flow is classified as laminar if blood travels in undisturbed streamlines or as
turbulent if blood undergoes irregular fluctuations and chaotic velocity changes [65]. High-ESS
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and laminar flow have shown to increase vascular NO bioavailability, and contrarily, low-ESS
and turbulent flow independently impair endothelial NO production [66]. However, some studies
have found that turbulent flow may be beneficial for vascular health. As an example, Gurovich
and Braith [67] evaluated blood flow patterns created by enhanced external counterpulsation and
its effects on femoral and brachial flow-mediated dilation (FMD) in 18 healthy young males.
They found that enhanced external counterpulsation generated retrograde turbulent blood flow in
the femoral artery and that this blood flow pattern improved femoral FMD. In addition, Gurovich
and Braith [68] analyzed blood flow patterns in the brachial and femoral arteries during
endurance and resistance exercise of 8 young healthy males and they described the presence of
turbulence blood flow when workloads were at 40% or above their maximal exertional capacities
during both types of exercises. The beneficial effects of exercise in vascular health are well
established [21] and the fact that turbulent blood flow is developed during these conditions
suggests that turbulence may also be favorable for the vasculature. Moreover, Cheng et al. [69]
reported that disturbed blood flow offered plaque stability to atherosclerotic lesions in the carotid
artery of an in vivo animal model, which could be considered as another example where turbulent
blood flow may not be detrimental for the endothelium.

2.3. High Blood Pressure
2.3.1. Definition, Classification, and Epidemiology
High blood pressure is the most common cause of CVD (e.g. coronary heart disease,
heart failure, stroke, myocardial infarction, atrial fibrillation, and peripheral artery disease),
chronic kidney disease, and cognitive impairment [8]. Cardiovascular risk increases in a loglinear manner with blood pressure beginning from <115/75 mmHg to >180/105 mmHg [70]. The
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operational definition of high blood pressure in adults is two or more office blood pressure
measurements obtained on two or more visits that are >120 mmHg for SBP or ≥80 mmHg for
DBP [7]. Even though there is no clear threshold level of blood pressure that defines when endorgan damage starts, an operational definition of high blood pressure is useful to simplify the
diagnosis and guide the management of this condition [71]. Currently, high blood pressure is
conceptually defined as the level of blood pressure at which there are more benefits of using an
evidence-based treatment (e.g. lifestyle interventions, drugs) than risks [6]. Table 2 displays the
most current classifications of high blood pressure published by the Seventh Joint National
Committee (JNC 7) [72], the American College of Cardiology/American Heart (ACC/AHA)
Association Task Force [7], and the European Society of Cardiology/European Society of
Hypertension (ESC/ESH) [6].

Table 2. Blood Pressure Classification
SBP
DBP
(mmHg)
(mmHg)
<120
and
<80
120-129 and
<80
130-139 or
80-89
140-159 or
90-99
160-179 or 100-109
≥180
or
≥110

JNC 7
(2003) [72]
Normal BP
Pre-HTA
Pre-HTA
Stage 1 HTA
Stage 2 HTA
Stage 2 HTA

ACC/AHA
(2017) [7]
Normal BP
Elevated BP
Stage 1 HTA
Stage 2 HTA
Stage 2 HTA
Stage 2 HTA

ESC/ESH
(2018) [6]
Optimal BP
Normal BP
High normal BP
Grade 1 HTA
Grade 2 HTA
Grade 3 HTA

BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; HTA: hypertension.

The 2017 ACC/AHA guidelines reclassified high blood pressure categories into elevated
blood pressure (SBP between 120-129 mmHg and DBP <80 mmHg), stage 1 hypertension (SBP
between 130-139 mmHg or DBP between 80-89 mmHg), and stage 2 hypertension (SBP
between ≥140 mmHg or DBP ≥90 mmHg) [7]. The first two categories proposed by the
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ACC/AHA were previously defined by the JNC 7 as prehypertension. The use of the term
prehypertension was intended to generate awareness among individuals with this range of blood
pressure and to encourage health care professionals to promote healthy habits. Nonetheless, these
goals were not accomplished, and less health care was provided [73]. The evidence behind the
reduced blood pressure threshold to define hypertension by the ACC/AHA is based on nine
longitudinal clinical studies in which major CVD events and the combination of fatal and
nonfatal stroke were significantly lower when blood pressure was maintained below 130/80
mmHg [7]. However, as emphasized by The American College of Physicians and the American
Academy of Family Physicians, no statistical benefit was found in CVD mortality when blood
pressure was below 130/80 mmHg [74]. Despite the reduction on the threshold to define
hypertension, the ACC/AHA guidelines still advocate for non-pharmacological interventions
(e.g. exercise) as the primary treatment option for elevated blood pressure or stage 1
hypertension with an estimated 10-year risk of CVD of <10%. Overall, the ACC/AHA blood
pressure classification allows early recognition of cardiovascular risk in individuals with high
blood pressure and further management through lifestyle interventions [17].
The prevalence of high blood pressure is dependent on the blood pressure cut off values
established to define hypertension. For example, according to the National Health and Nutrition
Examination Survey (NHANES), if hypertension is defined according to the JNC 7
recommendations, approximately 34% of US adults (85.7 millions) have hypertension,
meanwhile, if the ACC/AHA classification is taken into consideration, the prevalence of
hypertension in US adults rises to 46% (116.0 million). High blood pressure has a great impact
on the health care system with an estimated cost of $51.2 billion. Projected figures suggest that
the cost will increase up to $200 billion by 2030 [1].
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2.3.2. Etiology
High blood pressure is a multifaceted gene disorder exacerbated by environmental
factors, including high-salt intake, physical inactivity, smoking, and alcohol consumption [7]. A
total of 120 single-nucleotide polymorphisms associated with blood pressure homeostasis have
been identified, but they only can explain ~3.5% of the trait variance [75]. Primary hypertension
is defined as high blood pressure that cannot be explained by a secondary cause, like renal
parenchymal disease, renovascular disease, primary aldosteronism, obstructive sleep apnea,
pheochromocytoma, and Cushing’s syndrome among others, representing 95% of all cases of
high blood pressure. The remaining 5% of the cases are classified as secondary hypertension
[71].

2.3.3. Pathophysiology
The development of high blood pressure in humans requires the malfunction of one or
more factors involved with blood pressure control. According to the Mosaic Theory [22], there
are common molecular mechanisms that govern the events occurring at both cellular and organ
level in high blood pressure. Those mechanism will be described in the following sections.

2.3.3.1. Endothelial Dysfunction
Endothelial dysfunction is a pathological vascular state characterized by an unbalance
between vasodilatory and vasoconstrictory mechanisms [76], and generally defined as the
decrease in NO bioavailability within the endothelium [77]. Endothelial dysfunction is
considered a central feature in high blood pressure pathology. High-salt intake promote water
retention and subsequent blood pressure elevation. Healthy individuals can regulate blood
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pressure after high-salt intake due to the continuous release of NO from the endothelium that
produces vasodilation. When the endothelium is dysfunctional, blood pressure rises mainly
because NO levels are significantly reduced and levels of potent vasoconstrictors (e.g.
endothelin-1) are significantly elevated. Additionally, high-salt intake in susceptible individuals
with high blood pressure is associated with an elevation of transforming growth factor-β that
leads to fibrosis, oxidative stress, and reduction of NO. Moreover, endothelial dysfunction can be
directly exacerbated by angiotensin II, aldosterone, and oxidative stress. Angiotensin II
deteriorates endothelial function by direct vascular injury from oxidative stress and inflammatory
pathways. Meanwhile, aldosterone has shown to promote endothelial dysfunction by increasing
vascular smooth muscle cell proliferation, extracellular matrix deposition, collagen turnover,
vascular fibrosis, and oxidative stress. Simultaneously, oxidative stress is known to affect
endothelial function by converting NO into peroxynitrite [8].

2.3.3.2. Oxidative Stress
Reactive oxygen species (ROS) are oxygen metabolites such as superoxide (O2-) that can
accept electrons from other molecules, donate electrons to other molecules, or react and combine
with other molecules. In the case that nitrogen molecules such as NO are involved in redox
reactions, they receive the denomination of reactive nitrogen species (RNS). To counterbalance
ROS production, the body has several antioxidant pathways to buffer redox reactions. As an
example, superoxide dismutase (SOD) converts O2- into water and hydrogen peroxide (H2O2),
the latter molecule in turn is converted to oxygen and water by catalase [78].
Oxidative stress refers to a state of imbalance in which ROS and RNS production
overcomes the antioxidant capacity of the body [79]. Major sources of vascular ROS are
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nicotinamide adenine dinucleotide phosphate hydrogen oxidase (NOX), uncoupled eNOS,
xanthine oxidase, and the mitochondria [80]. Related to high blood pressure, a vicious cycle is
observed in vessels where O2- produced by NOX combines with NO, which is synthesized by
eNOS, and forms peroxynitrite. Then, eNOS is destabilized by peroxynitrite and its unstable
form produces more O2-. In addition, oxidative stress can lead to a deficit of eNOS cofactors
tetrahydrobiopterin (BH4) and L-arginine. All these reactions promote a reduction in NO
bioavailability [79]. Oxidative stress has been associated to high blood pressure in both
animal[81] and human studies [82] and it appears to exacerbate several mechanisms involved
with blood pressure regulation [8,78,83].

2.3.3.3. Inflammation
High blood pressure is known to be part of an inflammatory process [84-86]. This
inflammatory process consists of complex interactions between inflammatory cells and the
immune system [8]. An inflammatory state leads to increased expression of adhesion molecules
in the vasculature and the release of inflammatory cytokines, chemokines, matrix
metalloproteinases, and growth factors that promotes the thickening of the intima, vascular
fibrosis, degradation of extracellular matrix, and end-organ infiltration by immune cells
[8,83,84]. Levels of inflammatory cytokines such as IL-6 and TNF-α are elevated in individuals
with high blood pressure in comparison to normotensive individuals [85-89]. For its part, CRP
has been employed as a biomarker for systemic inflammation in CVD and its levels have been
positively correlated to SBP and end-organ damage in individuals with high blood pressure [90].
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2.3.3.4. Autonomic Dysfunction
The autonomic nervous system regulates blood pressure through a balance between
sympathetic and parasympathetic activity. When blood pressure rises, baroreceptors located in
the carotid sinus and aortic arch sense the arterial stretching and send a message to the brain to
reduce sympathetic outflow impulses which in turn reduces blood pressure [8]. The sympathetic
nervous system is more active in individuals with high blood pressure [91] and that this
increased activity induces α-1 adrenergic receptor-mediated endothelial dysfunction,
vasoconstriction, release of renin, vascular smooth muscle proliferation, and arterial stiffness
[92].

2.3.3.5. The Renin–Angiotensin–Aldosterone System
The renin-angiotensin-aldosterone system is critical in the maintenance of blood pressure.
Renin is an enzyme synthesized by juxtaglomerular cells that is released into the bloodstream in
response to a reduction in renal afferent arteriolar perfusion pressure, a reduction in sodium
levels, renal sympathetic nerves activation, or under the presence of vasodilators (e.g.
prostaglandin E2). Renin hydrolyzes angiotensinogen secreted from the liver into angiotensin I
that is then converted into angiotensin II by the angiotensin-converting enzyme. Angiotensin II is
known to bind the type 1 angiotensin II receptor which triggers arteriolar vasoconstriction,
sympathetic hyperactivity, sodium reabsorption, fluid retention, and the release of anti-diuretic
hormone and aldosterone. Aldosterone is also involved with water and sodium reabsorption
[8,93]. Individuals with high blood pressure have elevated plasma levels of renin and angiotensin
II [94] and the first phase for high blood pressure development is likely due to renal
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vasoconstriction induced by hyperactivation of both the sympathetic and the renin-angiotensinaldosterone systems [83].

2.3.3.6. Natriuretic Peptides Deficiency
Natriuretic peptides, such as atrial natriuretic peptide and brain natriuretic peptide, are
released by the atrium and ventricle after a stretch signal secondary to blood volume expansion
due to sodium intake. Both peptides reduce blood pressure by inducing vasodilation, shifting
fluid to the interstitial space, increasing glomerular filtration, and reducing sodium reabsorption.
Natriuretic peptide deficiency is another factor that favors high blood pressure [8].

2.3.3.7. Arterial Stiffness
Arterial stiffness can be defined as the rigidity of arterial walls and reflects the
fragmentation and loss of elastin with the overproduction and accumulation of collagen, mainly
at the media layer, but some experiments have shown that the adventitia layer is also involved.
Arterial compliance is determined by the ratio between elastin and collagen and is inversely
proportional to arterial stiffness. Aging and high blood pressure are associated with a decreased
ratio of elastin/collagen. Increased intraluminal pressure due to high blood pressure stimulates
collagen production to compensate for microfractures of elastin fibers. Additionally, matrix
metalloproteinases produced by inflammatory pathways intensify elastin degradation and
collagen deposition. Elastic arteries are the main vessels to be affected by arterial stiffness while
resistance vessels are usually not compromised. Endothelial dysfunction, angiotensin II,
aldosterone, and oxidative stress stimulate vascular hypertrophy and matrix remodeling, favoring
arterial stiffness [26,95]. Likewise, arterial stiffness increases afterload, reduces cardiac
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perfusion during diastole, and increases PP. The latter can be a determinant for end-organ
microvascular damage due to the rise of blood flow [96].

2.3.4. Cardiovascular Risk Factors and Quality of Life
A cardiovascular risk factor refers to a measurable variable associated to the presence of
CVD and at the same time is an independent risk predictor for the development of CVD [97].
The most common risk factor for CVD is peripheral high blood pressure [1]. SBP, DBP, and PP
have independently been associated to CVD [7]. High blood pressure accounts for approximately
10 million deaths and 200 million disability-adjusted life years worldwide. SBP ≥ 140 mmHg
explains around 70% of the mortality and disability burden [6]. Individuals with elevated blood
pressure or stage 1 hypertension have a greater chance to progress to stage 2 hypertension and to
develop CVD and chronic kidney disease in comparison to normotensive individuals [1].
Additionally, high blood pressure is commonly associated to other cardiovascular risk factors,
such as central blood pressure, cardiorespiratory fitness, arterial stiffness, dyslipidemia, and
obesity.
Central blood pressure reflects the pressure at the aortic wall and has shown to be more
strongly related to future cardiovascular events than traditional brachial blood pressure [98]. As
an example, central systolic blood pressure (cSBP) and central pulse pressure (cPP), rather than
brachial pressures, were independently associated with cardiovascular mortality and events in
2,403 American Indians in a follow-up study with a mean duration of 4.8 years [99].
Cardiorespiratory fitness refers to the ability of the cardiovascular system to supply
oxygen for muscle contraction during physical activity. Maximal oxygen uptake (VO2max) is the
maximum rate of oxygen consumption measured during an incremental cardiopulmonary test
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and reflects the integrity of the cardiovascular system. VO2max is an independent predictor of
CVD mortality [100,101].
Arterial stiffness, besides being part of the physiopathology of high blood pressure, is an
independent predictor of all-related cardiovascular causes of mortality, coronary morbidity, and
fatal stroke in individuals with high blood pressure. The reference standard technique to assess
arterial stiffness is PWV [102].
Dyslipidemia refers to a disruption of the lipid metabolism and is reflected by plasma
elevations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very lowdensity lipoprotein cholesterol (VLDL-C), or triglycerides (TG) or a reduction of high-density
lipoprotein cholesterol (HDL-C) [103]. Each parameter of the lipid profile has been shown to be
a strong independent predictor for CDV [104]. Dyslipidemia is a risk factor for atherosclerosis
and it has been reported that lower levels of LDL-C and TC are associated to better health
outcomes [105].
Obesity is an abnormal accumulation of body fat which increases the risk for CDV. BMI
is the most common assessment to define obesity and involves the ratio between weight and the
square of height [106,107]. However, BMI misclassifies cardiometabolic health [108] and
doesn’t consider body fat distribution (e.g. visceral type) [109]. Current approaches advocate for
the use of body composition as an assessment tool to determine obesity [110].
Finally, quality of life refers to the subjective evaluation of the bio-psycho-social
wellness of an individual and includes aspects related to physical and mental health, relationships
with the community, workplace, friends, family, and personal goals [111]. Several studies have
reported that individuals with high blood pressure tend to have significantly worse scores in
surveys related to quality of life in comparison to normotensive individuals [112-115].
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2.4. Physical Activity and Exercise
2.4.1. Definitions and Epidemiology
Physical activity refers to any type of body movement originated by skeletal muscle
contractions that results in energy expenditure [116] categorized in leisure-time physical activity
or occupational physical activity. Leisure-time physical activity comprises those activities that
happen during spare time and are based on personal interest or needs (e.g., sports participation,
exercise training programs, playing music, walking, hiking, etc.), while occupational physical
activity covers those activities that are developed during a typical 8- to 12-hour work shift [117].
Exercise is a subtype of leisure-time physical activity that is planned, structured, and
repetitive, which’s goal is to improve or maintain one or more features of physical fitness (e.g.,
cardiorespiratory endurance, muscle endurance, muscle strength, muscle power, flexibility,
agility, balance, agility, and body composition) [117,118]. From a mechanistic point of view,
exercise can be described as dynamic or static. Dynamic exercise, also known as isotonic, allows
movement of the arms, legs, or trunk in a concentric or eccentric pattern. Static or isometric
exercise generates muscle contraction without movement of the limbs or trunk [119]. At the
same time, exercise can be described according to the metabolic contribution from the
phosphagen, glycolytic, and oxidative phosphorylation energy pathways for muscle contraction.
Current efforts have been made to abolish the terms “aerobic” and “anaerobic” exercise because
they misrepresent the connections among the energy pathways involved with the physiology of
muscle contraction [120]. For example, lactate is a metabolic product of glycolysis that doesn’t
require oxygen for its production. Once it is formed, lactate can be transported inside the
mitochondria and it can be used as a fuel source by the oxygen-dependent oxidative
phosphorylation pathway [121]. Also, all three energy pathways operate simultaneously during
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exercise but one of them predominates over the other two depending on the intensity and
duration of the exercise bout [122,123].
A physically inactive adult is defined as someone that covers less than 150 minutes of
moderate-to-vigorous physical activity per week or less than 75 minutes of vigorous physical
activity per week [124,125]. Physical inactivity is considered the fourth cause of death
worldwide [126] and represents a major risk factor for CVD. Estimates suggests that only 21.6%
of US adults met the criteria for minimal physical activity recommendations. Translating this
into economical costs, physical inactivity represents 1.5% to 3.0% of total direct healthcare
expenditures [1]. For every dollar invested to increase physical activity in the community, there
is a savings of three to six dollars in healthcare [1,19]. Similarly, this trend is also observed in
CVD individuals who follow cardiovascular rehabilitation programs. Long-term retention rates
ranges from 21% to 50% [35-37]. Multiple factors affect the decision to drop out from an
exercise program such as personality, intrinsic motivation, personal preferences to exercise, and
organizational characteristics [38-42]. The incorporation of more exercise alternatives to the
traditional physical activity programs (e.g. walking, running, cycling, and resistance training)
might avoid the large dropout from cardiovascular rehabilitation programs and attract more
people to start exercising [35,43,44]. Nonetheless, before a nontraditional modality of exercise
can be recommended for health-related conditions and incorporated into cardiac rehabilitation
programs, a solid scientific background must exist [45].

2.4.2. Exercise Prescription in Cardiovascular Diseases
Exercise prescription in CVD commonly refers to an individualized fitness program
designed by a healthcare professional that seeks to: (1) prevent or treat a cardiovascular
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condition, (2) improve cardiovascular risk factors (e.g., blood pressure, glycemia, lipid profile,
central adiposity, physical inactivity, and sedentary behavior), and (3) boost one or more
components of physical fitness like cardiorespiratory endurance, muscular strength, muscular
power, muscular endurance, flexibility, balance, body composition, agility, coordination, or
balance [127,128].
The basic principles to prescribe exercise are: (1) modality, (2) intensity, (3) duration, (4)
frequency, and (5) progression[127].
Modality refers to the type of activity that will be performed. The most common exercise
modalities selected to explore exercise-induced effects on the cardiovascular system are walking,
running, cycling, and resistance training [18,30,129-137]. Cardiovascular adaptations are
modality-dependent [21,138]. For example, Pelliccia et al. [139] described that endurance sports
are associated with a higher left ventricle mass in comparison to strength sports. Additionally,
Boraita et al. [140] showed that although the aortic root size of 3,1281 elite athletes was within
the normal range for the general population, elite athletes participating in endurance sports had
larger aortic dimensions in comparison to those elite athletes from strength-focus disciplines.
Nonetheless, these cross-sectional studies have the limitation of introducing bias due to the intersubject variability. To solve the inherent limitations of cross-sectional studies, Spence et al. [141]
designed a prospective randomized longitudinal study to evaluate the impact of different exercise
modalities in the vasculature. They found that upper-body resistance training increased the
resting diameter and the function of the brachial artery but these characteristics remained
unchanged in the femoral artery, while lower-body endurance training only improved the
structure and the functionality of the femoral artery. No changes were observed in the resting
diameter and the function of the brachial artery. Moreover, metabolic responses to exercise are
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also dependent on the modality. Dufour et al. [142] and Peñailillo et al. [143] reported that HR,
blood lactate, and VO2 were significantly lower in eccentric cycling compared to concentric
cycling.
Intensity is the degree of effort employed during exercise that can be expressed as
absolute intensity (total rate of energy expenditure for a specific activity) or relative intensity
(percentages of an absolute value). Absolute intensity parameters include oxygen uptake
(L/min), oxygen uptake normalized to body mass (ml/kg/min), energy (kcal/min), and multiples
of the resting metabolic rate (METs). Relative intensity can be described as a percentage of
maximal oxygen uptake (VO2max), oxygen uptake reserve (VO2R), peak oxygen uptake
(VO2peak), maximal heart rate (HRmax), heart rate reserve (HRR), and one-repetition maximum
(1-RM) for resistance training [117]. Other alternatives to quantify intensity are the classification
of the exertion according to ventilatory thresholds, lactate threshold, and Borg’s Rating of
Perceived Exertion (RPE). Few studies have determined the cardiovascular adaptations to
different exercise intensities. Goto et el. [144] evaluated the effects of 12-weeks of cycling at
three different intensities (25% VO2max, 50% VO2max, and 75% VO2max) on the endotheliumdependent vasodilatory response. They found that only moderate-intensity exercise (50%
VO2max) increased the endothelium-dependent vasodilatory response while high-intensity
increased plasma levels of oxidative stress. In contrast, Rakobowchuk et al. [145] described
similar improvements in arterial stiffness after six weeks of sprint interval training (six 30second “all-out” cycling, 4.5-minute of active recovery between each bout, three days per week)
and endurance training (40-60 minutes of cycling at 65% VO2peak, five days per week). A metaanalysis [136] comparing the effects of HIIT and moderate-intensity continuous training on
vascular function favored HIIT.
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Duration is defined as the amount of time expended during exercise and can be performed
continuously or intermittently. For the specific case of resistance training, volume (number of
sets and repetitions per exercise) is used instead of duration. Depending on the amount of
intensity and duration, exercise protocols can range from moderate-intensity continuous training
to high-intensity interval training (HIIT). For example, continuous exercise can be applied at
low- and moderate-intensity during an extended period (e.g. 60 min) while HIIT is based on
intervals of maximal effort for a short period (e.g. 30 seconds to 4 minutes) interspersed by
recovery time at low-intensity. Polarized training is comprised of an exercise session where 7080% of the time is performed at low-intensity (just below lactate threshold or first ventilatory
threshold) and the remaining 20-30% of the time is performed using HIIT. Data suggest that
polarized training might be more beneficial for cardiovascular health than moderate-intensity
continuous exercise or HIIT alone [146].
Frequency pertains to the number of times that an exercise session is carried out during
certain period (e.g. 3 times per week, 2 times per day). Most studies employing exercise training
as an intervention have shown benefits for health when the frequency is at least 3 to 5 sessions
per week [147].
Progression refers to the periodical adjustment of any of the previous variables that will be
dependent on the individual’s training responses and the exercise programs objectives [127].

2.4.3. Boxing Training
Boxing training is a nontraditional exercise modality characterized by stand-up punching,
coordinated body movements, balance, and agility that requires high levels of endurance,
strength, and technical skills. A boxing training session can include several types of drills like

29

shadowing, sparring, heavy bag punching, speed bag, mitt work, skipping, jumping the rope,
footwork, running, technique development, and core exercises. A current popular approach
among fitness centers is the use of non-contact boxing classes which include all the activities of
boxing training, except for sparring. Usually, a workout is divided into rounds of two to three
minutes of exercise at high-intensity followed by a resting period of one minute [46,48,148-150].
It has been described that boxing training elicits a great metabolic response. For example, Ghosh
[150] showed that amateurs young boxers evoked high metabolic responses during a boxing
round with mean peaks of VO2, HR, and lactate of ~58 ml/kg/min, 192 bpm, and 13.6 mmol/L,
respectively.
Very few studies have employed boxing training as an intervention to improve health in
CVD. In a case report, Shultz et al. [53] evaluated the impact in cardiometabolic variables of a
12-week program that combined 30-minute boxing training and 30-minute resistance training
three times per week in three obese male adolescents. The boxing program included shadow
boxing, heavy bag punching, and mitt punching at an intensity of 90% HRmax. The resistance
protocol consisted of at least six exercises of major muscle groups at 70-90% HRmax. The authors
described a reduction in visceral fat thickness and carotid β-stiffness index and improvements in
VO2max and AIx. In another study, Cheema et al. [52] recruited twelve adults with abdominal
obesity for a 12-week pilot randomized parallel pilot trial to assess the effectiveness of boxing
training in obesity, cardiovascular outcomes, and quality of life in comparison to walking. The
boxing group (n = 6) underwent 50 minutes of boxing training four times per week that included
a 5-minute warm up of skipping followed by three series of five rounds for each of the
following: heavy bag punching, focus mitts, circular body bag, footwork, and skipping. Each
round was composed by two-minute high-intensity exercise at 86-89% HRmax followed by one-
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minute of rest. Meanwhile, the control group (n = 6) completed 50 minutes of unsupervised
continuous brisk walking at 64-77% HRmax, four times per week. In the boxing group, they found
a statistically significant post-intervention reduction in percent body fat (%BF), brachial blood
pressure, and AIx with improvements in both VO2max and quality of life. Similarly, Yli-Piipari
et al. [151] evaluated the effects of boxing training in conjunction with a 12-week lifestyle
program on cardiometabolic and psychological outcomes in Hispanic children and adolescents.
A total of 22 children and adolescents with a BMI above the 85th percentile for their age were
recruited for a case series study where they underwent one-hour of boxing training twice per
week, one-hour nutritional education once per week, group meetings for behavior modifications,
and one meeting with a pediatrician to reinforce the motivation. This program showed a
statistically significant reductions in waist circumference, BMI, and glycemic control along with
significant improvements in intrinsic motivation and introjected regulation. Lastly, Park et al.
[49] evaluated the effects of boxing training on upper limb function, balance, gait, and quality of
life in 30 stroke patients. Randomly dividing the sample into two groups, the first group (boxing,
n = 15) underwent 30 minutes of boxing training (5-minute warming up, 10-minute mitt
punching, 10-minute heavy bag punching, and 5-minute cooling down) followed by 30 minutes
of physical therapy, 3 times a week for 6 weeks. The second group (control, n = 15) only
performed 30 minutes of physical therapy 3 times a week for 6 weeks. During the first 2 weeks,
the boxing sessions were in a sitting position, then evolved to an alternation of sitting and
standing for the following 4 weeks. They showed that boxing training significantly improved the
functionality of the upper limb, the dynamic component of balance, the walking ability, and
quality of life. Additionally, boxing training has been applied as a complementary therapy in
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Parkinson’s disease where patients have shown promising results regarding their clinical
evolution [50,152].

2.4.4. Exercise Effects on the Cardiovascular System in Individuals with High Blood
Pressure
2.4.4.1. Peripheral Blood Pressure
Comprehensive meta-analyses have shown that exercise significantly reduces brachial
blood pressure and can be employed as an effective treatment intervention in individuals with
high blood pressure [18,28,29]. Cornelissen et al. [18] described an overall reduction in
SBP/DBP of 3.5/2.5, 1.8/3.2, and 10.9/6.2 mmHg in endurance, resistance, and isometric
training, respectively. According to their results, at least 30 minutes of moderate- or highintensity exercise training were required to reduce blood pressure. No difference in blood
pressure was observed between exercise frequencies (e.g., 3, 4, or >4 times per week). Similarly,
de Sousa et al. [28] found reductions of 8.2/4.1 mmHg in a meta-analysis that involved resistance
training as a single intervention in individuals with high blood pressure. Meanwhile, Inder et al.
[29] in another meta-analysis depicted 5.2/3.9 mmHg reductions after isometric exercise training
in healthy and individuals with high blood pressure. Table 3 describes protocols and outcomes of
randomized trials involving exercise training in individuals with high blood pressure.
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Table 3. Characteristics of previous studies that evaluated the effects of exercise on systolic
and diastolic blood pressure in individuals with high blood pressure.
Author
Duncan et al. [153]

Year
1985

Design
RCT

N
56

Modality
Walking
Jogging
Walking
Jogging
Cycling

Frequency
3 d/wk

Intensity
75% HRpeak

Duration
60 min/d

Period
16 wks

Hagberg et al. [154]

1989

RCT

30

3 d/wk

Low: 53% VO2max
Mod: 73% VO2max

51 min/d

37 wks

Tanabe et al. [155]

1989

RCT

31

Cycling

3 d/wk

40-60% VO2peak

60 min/d

10 wks

Martin et al. [156]

1990

RCT

27

4 d/wk

65-80% HRpeak

30 min/d

10 wks

1994

RCT

44

Walking
Jogging
Cycling
Mod:
Walking
High:
Uphill
Walking

Braith et el. [157]

3 d/wk

Mod: 70% HRR
High: 85% HRR

45 min/d

26 wks

Anderssen et al.
[158]
Kokkinos et al.
[159]
Ready et al. [160]

1995

RCT

90

3 d/wk

60-80% HRpeak

60 min/d

52 wks

1995

RCT

46

Walking
Jogging
Cycling

3 d/wk

74% HRmax

44 min/d

16 wks

1996

RCT

53

Walking

3 d/wk
5 d/wk

60% VO2max

60 min/d

24 wks

Tanaka et al. [161]

1997

RCT

18

Swimming

3 d/wk

60% VO2peak

45 min/d

10 wks

Jessup et al. [162]

1998

RCT

21

3 d/wk

85% HRpeak

45 min/d

16 wks

Murphy et al. [163]

1998

RCT

34

Walking
Stair
climbing
Brisk
Walking

5 d/wk

70-80 HRpeak

10 wks

4 wks

Outcome
SBP ↓ 12 mmHg
DBP↓ 7 mmHg
Low:
SBP ↓ 6 mmHg
DBP↓ 9 mmHg
Moderate:
SBP ↓ 7 mmHg
DBP↓ 3 mmHg
SBP ↓ 15 mmHg
DBP↓ 7 mmHg
SBP ↓ 6 mmHg
DBP↓ 10 mmHg
Mod:
SBP ↓ 9 mmHg
DBP↓ 8 mmHg
High:
SBP ↓ 8 mmHg
DBP↓ 7 mmHg
SBP ↓ 5 mmHg
DBP↓ 5 mmHg
SBP ↓ 7 mmHg
DBP↓ 5 mmHg
3 d/wk:
SBP ↓ 7 mmHg
DBP↓ 3 mmHg
5 d/wk:
SBP ↓ 5 mmHg
DBP↑ 1 mmHg
SBP ↓ 6 mmHg
DBP↓ 2 mmHg
24-hr ABPM:
SBP ↓ 8 mmHg
DBP↓ 4 mmHg
5 d/wk:
SBP ↓ 5 mmHg
7 d/wk:
SBP ↓ 7 mmHg
SBP ↓ 9 mmHg
DBP↓ 7 mmHg
SBP ↑ 8 mmHg
DBP↑ 3 mmHg
SBP ↓ 8 mmHg
DBP↓ 4 mmHg
SBP ↓ 7 mmHg
DBP↓ 4 mmHg
SBP ↓ 3 mmHg
DBP↓ 5 mmHg
SBP ↓ 3 mmHg
DBP↓ 7 mmHg
SBP ↓ 11 mmHg
DBP ↔
SBP ↓ 7 mmHg
DBP↓ 4 mmHg
SBP ↓ 11 mmHg
DBP↓ 5 mmHg
SBP ↓ 18 mmHg
DBP↓ 10 mmHg
SBP ↑ 4 mmHg
DBP↓ 1 mmHg
SBP ↓ 10 mmHg
DBP↓ 6 mmHg

Sakai et al. [164]

1998

RCT

29

Cycling

3 d/wk

40-60% VO2peak

5 d/wk:
60 min/d
7 d/wk:
3 x 10min/d
60 min/d

Hamdorf et al.
[165]
Higashi et al. [166]

1999

RCT

38

Walking

2 d/wk

40% HRR

25 min/d

26 wks

1999

RCT

27

5-7 d/wk

52% VO2peak

30 min/d

12 wks

Higashi et al. [167]

1999

RCT

17

5-7 d/wk

52% VO2peak

30 min/d

12 wks

Georgides et al.
[168]
Hass et al. [169]

2000

RCT

55

3-4 d/wk

70-85% HRR

45 min/d

26 wks

2001

RCT

26

3 d/wk

75% HRR

40 min/d

12 wks

Moreu et al. [170]

2001

RCT

24

Walking
Jogging
Walking
Jogging
Walking
Cycling
Recumbent
Step training
Walking

24 wks

Staffileno et al.
[171]
Tsai et al. [172]

2001

RCT

18

5 d/wk

50-60% HRR

2002

RCT

42

3 d/wk

60-70% HRpeak

Tsai et al. [173]

2002

RCT

23

3 d/wk

60-70% HRpeak

30 min/d

12 wks

Asikainen et al.
[174]
Jessup et al. [175]

2003

RCT

130

Walking
Cycling
Walking
Jogging
Walking
Jogging
Walking

9700
steps/day
3 x 10
min/day
30 min/d

5 d/wk

65% VO2peak

300 kcal/d

15 wks

2003

RCT

30

2 d/wk

75% HRpeak

45 min/d

16 wks

Tsuda et al. [176]

2003

RCT

16

2 d/wk

AT

50 min/d

26 wks

SBP ↓ 10 mmHg
DBP↓ 6 mmHg

Santa-Clara et al.
[177]

2003

RCT

60

3-4 d/wk

70-85% HRpeak

45-60 min/d

26 wks

SBP ↔
DBP↓ 4 mmHg

Maeda et al. [178]

2004

RCT

15

Walking
Cycling
Stair
climbing
Walking
Jogging
Calisthenics
Walking
Cycling
Rowing
Cycling

5 d/wk

80% VT

30 min/d

12 wks

Tsai et al. [179]

2004

RCT

102

Walking
Jogging

3 d/wk

60-70% HRpeak

30 min/d

10 wks

SBP ↓ 12 mmHg
DBP↓ 7 mmHg
SBP ↓ 13 mmHg
DBP↓ 6 mmHg

7 d/wk

7 d/wk
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8 wks
12 wks
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Murtagh et al. [180]

2005

RCT

49

Bisk walking

3 d/wk

73% HRpeak

20 min/d

12 wks

Tully et al. [181]

2005

RCT

26

Bisk walking

5 d/wk

“slightly breathless”

30 min/d

12 wks

Church et al. [182]

2007

RCT

464

Walking
Jogging
Cycling

3 d/wk

50% VO2peak

28 min/d
49 min/d
62 min/d

26 wks

Tully et al. [183]

2007

RCT

93

Walking

3 d/wk
5 d/wk

“slightly breathless”

30 min/d

12 wks

Brixius et al. [184]

2008

RCT

21

Running
Cycling

3 d/wk

Lactate 3 mmol/L

60-90
min/day

24 wks

Westhoff et al.
[185]
Krustrup et al.
[186]

2008

RCT

24

3 d/wk

Lactate 2 mmol/L

30 min/day

12 wks

2009

RCT

32

Upper-limb
cycling
Soccer
Running

2-3 d/wk

82% HRpeak

60 min/day

12 wks

Dalleck et al. [187]

2009

RCT

26

Walking

5 d/wk

50% VO2R

30 min/day
45 min/day

12 wks

Hua et al. [188]

2009

RCT

40

Walking

4 d/wk

35-40% HRR

4.8 km/day

12 wks

Lamina et al. [189]

2010

RCT

357

Cycling

3 d/wk

60-79% HRpeak

60 min/day

8 wks

Saremi et al. [190]

2010

RCT

18

5 d/wk

80-85% HRpeak

2011

RCT

40

3 d/wk

60-80% HRpeak

50-60
min/day
44 min/day

12 wks

Pitsavos et al. [191]

Walking
Running
Cycling

Molmen-Hansen et
al. [192]

2011

RCT

88

Walking
Running
uphill

3 d/wk

Mod: 70% HRmax
HIIT: 4 x 4 min 9095% HRmax, 3 min
rest

Mod: 47
min/day
HIIT: 38
min/day

12 wks

Izadi et al. [193]

2018

RCT

30

Cycling

3 d/wk

HIIT: 10 x 1.5 min
85-90% HRR, 2 min
50-55% HRR

35 min

6 wk

Harris et al. [194]

1987

RCT

26

Resistance

3 d/wk

40% 1RM

9 wks

SBP ↓ 5 mmHg
DBP↓ 1 mmHg

Van Hoof et al.
[195]

1996

RCT

19

Resistance

3 d/wk

70-90% 1RM

16 wks

SBP ↓ 4 mmHg
DBP↓ 5 mmHg

Tsutsumi et al.
[196]

1997

RCT

41

Resistance

3 d/wk

High: 75-85% 1RM
Low: 55-65% 1RM

12 wks

Vincent et al. [197]

2003

RCT

62

Resistance

3 d/wk

High: 80% 1RM
Low: 50% 1RM

Colado et al. [198]

2009

RCT

31

Resistance

3 d/wk

Elastic bands

10 types
3 sets
20-25 reps
6 types
3 sets
10 reps
11 types
2 sets
High:
8-12 reps
Low:
12-16 reps
13 types
1 set
High:
8 reps
Low:
13 reps
8-16 types
2 sets
15-30 reps

High:
SBP ↓ 6 mmHg
DBP ↔
Low:
SBP ↓ 13 mmHg
DBP↓ 2 mmHg
High:
SBP ↓ 3 mmHg
DBP ↓ 2 mmHg
Low:
SBP ↔
DBP↔
DBP↓ 5 mmHg
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16 wks

24 wks

24 wks

SBP ↔
DBP ↔
SBP ↓ 12 mmHg
DBP↓ 4 mmHg
28 min/d:
SBP ↔
DBP ↔
49 min/d:
SBP ↓ 1 mmHg
DBP ↔
62 min/d:
SBP ↓ 3 mmHg
DBP ↔
3 d/wk:
SBP ↓ 6 mmHg
DBP ↔
5 d/wk:
SBP ↓ 6 mmHg
DBP↓ 3 mmHg
Running:
SBP ↔
DBP ↔
Cycling:
SBP ↓ 12 mmHg
DBP↓ 6 mmHg
SBP ↓ 7 mmHg
DBP↓ 6 mmHg
Soccer:
SBP ↓ 8 mmHg
DBP↓ 5 mmHg
Running:
SBP ↓ 8 mmHg
DBP↓ 5 mmHg
30 min/d:
SBP ↓ 2 mmHg
DBP↓ 2 mmHg
45 min/d:
SBP ↓ 5 mmHg
DBP↓ 2 mmHg
SBP ↓ 11 mmHg
DBP↓ 5 mmHg
SBP ↓ 15 mmHg
DBP↓ 4 mmHg
SBP ↓ 2 mmHg
DBP↓ 2 mmHg
SBP ↓ 12 mmHg
DBP↓ 7 mmHg
Mod:
SBP ↓ 5 mmHg
DBP↓ 4 mmHg
HIIT:
SBP ↓ 12 mmHg
DBP↓ 8 mmHg
SBP ↓ 3 mmHg
DBP↓ 2 mmHg
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Lovell et al. [199]

2009

RCT

24

Resistance

3 d/wk

70-90% 1RM

Incline squat
3 sets
6-10 reps

16 wks

SBP ↔
DBP↔

Laterza et al. [200]

2007

RCT

20

Cycling +
Resistance

3 d/wk

Cycling:
Resistance 70%
VO2peak

16 wks

SBP ↓ 15 mmHg
DBP↓ 10 mmHg

Guimaraes et al.
[201]

2010

RCT

56

Running +
Resistance

3 d/wk

16 wks

SBP ↔
DBP↔

Figueroa et al.
[202]

2011

RCT

24

Walking +
Resistance

3 d/wk

Continuous:
60% HRR
HIIT:
50% HRR/80%
HRR
60% HRmax

Cycling: 40
min
Resistance:
10 min of situps, pushups, pull-ups
40 min
endurance +
20 min
resistance

12 wks

SBP ↓ 6 mmHg
DBP↓ 5 mmHg

Okhubo et al. [203]

2001

RCT

39

Cycling +
Resistance

2-3 d/wk

60% HRR
Elastic bands

20 min
endurance +
20 min
resistance
25 min
endurance +
5 types

25 wks

SBP ↓ 5 mmHg
DBP↓ 4 mmHg

Wiley et al. [204]

1992

RCT

15

Isometric

3 d/wk

30% MVC

8 wks

SBP ↓ 13 mmHg
DBP↓ 15 mmHg

Taylor et al. [205]

2003

RCT

17

Isometric

3 d/wk

30% MVC

10 wks

SBP ↓ 19 mmHg
DBP↓ 7 mmHg

Badrov et al. [206]

2013

RCT

24

Isometric

3 d/wk

30% MVC

4 series
2 min/
3 min rest
4 series
2 min/
1 min rest
4 series
2 min/
1 min rest

10 wks

SBP ↓ 8 mmHg
DBP↓ 5 mmHg

Blumenthal et al.
[207]

1991

RCT

92

Resistance
Endurance

2-3 d/wk

70% VO2peak

30 min
resistance,
50 min
endurance

16 wks

Cononie et al. [208]

1991

RCT

49

Resistance
Endurance

3 d/wk

Resistance: 8-12 RM
Endurance: 75-85%
VO2peak

26 wks

Kraemer et al.
[209]

2001

RCT

35

Endurance
Resistance

3 d/wk

80-90% HRpeak

Resistance:
10 types
1 set
12 reps
Endurance:
35-45 min
Endurance:
40 min
Resistance:
25 min

Wood et al. [210]

2001

RCT

36

Endurance
Resistance
Combination

3 d/wk

Endurance:
60-70% HRR
Resistance:
8-12 RM

Endurance:
45 min
Resistance:
8 types
2 sets
8-12 reps

12 wks

Sarsan et al. [211]

2006

RCT

60

Endurance
Resistance

3-5 d/wk

Endurance:
50-85% HRR
Resistance:
75-80% 1RM

12 wks

Simons et al. [212]

2006

RCT

59

Walking
Resistance

2 d/wk

75% 1RM

Endurance:
30-45 min
Resistance:
6 types
3 sets
10 reps
Resistance:
6 types
1 set
10 reps

Collier et al. [213]

2008

PRT

30

Running
Resistance

3 d/wk

Running: 65%
VO2peak

Running: 30
min
Resistance:
9 types
3 sets
10 reps

4 wks

Resistance:
SBP ↓ 7 mmHg
DBP↓ 6 mmHg
Endurance:
SBP ↓ 8 mmHg
DBP↓ 6 mmHg
Resistance:
SBP ↔
DBP↔
Endurance:
SBP ↓ 8 mmHg
DBP↓ 9 mmHg
Endurance:
SBP ↔
DBP↓ 6 mmHg
Resistance:
SBP ↔
DBP↓ 7 mmHg
Endurance:
SBP ↓ 10 mmHg
DBP↓ 3 mmHg
Resistance:
SBP ↔
DBP↔
Combination:
SBP ↔
DBP↔
Endurance:
SBP↓ 10 mmHg
DBP↓ 7 mmHg
Resistance:
SBP↓ 6 mmHg
DBP↓ 8 mmHg
Walking:
SBP↓ 5 mmHg
DBP↔
Resistance:
SBP↓ 9 mmHg
DBP↔
Running:
SBP↓ 5 mmHg
DBP↓ 3 mmHg
Resistance:
SBP↓ 4 mmHg
DBP↓ 4 mmHg

35

12 wks

16 wks
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Silampää et al.
[214]

2009

RCT

62

Cycling
Resistance
Combination

2 d/wk

Cycling: above AT
Resistance: 10RM

Cycling: 6090 min
Resistance:
7-8 types
3-4 sets
6-8 reps

21 wks

Beck et al. [215]

2013

RCT

43

Running
Resistance

3 d/wk

Running: 65-85%
HRmax
Resistance: volitional
fatigue

8 wks

Cheema et al. [52]

2015

PRT

12

Walking
Boxing

4 d/wk

Walking: 64-77%
HRmax
Boxing:
2 min 86-89%
HRmax, 1 min rest

Running: 60
min
Resistance:
7 types
2 sets
8-12 reps
50 min/d

12 wks

Cycling:
SBP ↔
DBP↔
Resistance:
SBP↓ 7 mmHg
DBP↔
Combination:
SBP ↔
DBP↓ 4 mmHg
Running:
SBP↓ 12 mmHg
DBP↓ 3 mmHg
Resistance:
SBP↓ 10 mmHg
DBP↓ 7 mmHg
Walking:
SBP ↔
DBP↔
Boxing:
SBP↓ 14 mmHg
DBP↓ 7 mmHg

Note. RCT: randomized controlled trial; PRT: parallel randomized trial

2.4.4.2. Central Blood Pressure
In a recent meta-analysis that included 38 randomized controlled trials, Zhang et al. [30]
reported the effects of different exercise modalities on central blood pressure features such as
high blood pressure, coronary artery disease, heart failure, and stroke in 2,089 individuals with
CVD. They found that endurance training reduced cSBP, whereas resistance training reduced
cSBP and cDBP and combined exercise reduced cSBP, cDBP, and AIx. In a subgroup analysis
focused only in individuals with high blood performing endurance exercise, only cSBP showed a
significant reduction.

2.4.4.3. Cardiorespiratory Fitness
Longitudinal studies have shown an inverse association between increased
cardiorespiratory fitness and SBP [216-218]. Meanwhile, a meta-analysis that evaluated the
changes of VO2max after exercise training as a secondary outcome in individuals with high
blood pressure described a significant increase in VO2max for endurance and resistance trainings
[31].
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2.4.4.4. Arterial Stiffness
Two meta-analyses have compared the effect of exercise modalities on PWV. Ashor et al.
[32] described PWV improvements with endurance training but not with resistance training or a
combination of both endurance and resistance in healthy and CVD individuals. Meanwhile,
Zheng et al. [30] found that PWV was improved in CVD individuals by a combination of
endurance and resistance training and by endurance training alone.

2.4.4.5. Lipid Profile
The effects of endurance exercise on lipid metabolism in individuals with high blood
pressure were evaluated by Fagard in a meta-analysis [31]. Although TG, LDL-C, and HDL-C
levels improved, only the latter showed a statistical difference after exercise training.

2.4.4.6. Body Composition
Exercise alone has a low impact on weight loss but it has been observed that it can reduce
body fat and increase muscle mass. A meta-analysis [31] evaluating the effects of exercise
training on body composition in healthy sedentary normotensive and hypertensive adults
reported that endurance training induced a significant net reduction in weight by 1.2 kg,
percentage body fat (%BF) by 1.4%, and waist circumference by 2.8 cm. Meanwhile, resistance
training induced a significant net reduction in %BF by 0.94%. Lamina et al. [219] showed that
eight weeks of interval cycling significantly reduced %BF by 9.91% and waist-to-hip ratio by
0.08 in individuals with high blood pressure lacking comorbidities. Lima et al. [220] compared
the effects of endurance training, resistance training, and a combination of endurance and
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resistance training on body composition and anthropometric measures in older hypertensive
individuals. They reported a significant reduction in fat mass after only 10 weeks of resistance
training and a reduction in abdominal and waist circumferences after 10 weeks of endurance
training and 10 weeks of resistance training. In contrast, Son et al. [221] showed that 12 weeks of
combined resistance and endurance training significantly reduced %BF by 1.35% in 40 obese
high blood pressure female adolescents.

2.4.4.7. Cardiac Adaptations
The heart is one of the main end-organ targets affected by high blood pressure. Sustained
hypertension triggers several structural and functional adaptations in the heart to maintain
homeostasis where left ventricle hypertrophy (LVH) is the most remarkable due to its association
with cardiovascular mortality [222,223]. LVH also affects the ability of the ventricle to relax
during diastole, process known as diastolic dysfunction, where an increase in left atrium pressure
have been described. This raise in atrial pressure is followed by pulmonary congestion and in
some cases atrial fibrillation [224]. Reversion of LVH is associated with lower mortality rates
due to CVD [225]. Long-term endurance exercise training can also induce cardiac remodeling
and LVH, but this remodeling process involves different molecular pathways than high blood
pressure induced-LVH [226,227]. Interestingly, exercise training has shown a LVH reversion in
individuals with high blood pressure [226,228]. In a randomized controlled study, Kokkinos et
al. [159] examined the effects of 16 weeks of cycling at moderate intensity three times per week
on LVH in 46 high blood pressure adults (mean age 57.5 years old). They found significant
reductions in interventricular septal thickness, left ventricle mass, and left ventricle mass index.
A prospective study by Turner et al. [229] evaluated the effects of seven weeks of 30 to 50
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minutes of endurance training (brisk walking, jogging, or cycling) four times per week at 6080% HRmax on LVH in 18 high blood pressure older adults (mean age 66.5 years old) that were
divided into an exercise group (n = 11) or sedentary group (n = 7). They described a significant
decrease in left ventricle wall thickness and left ventricle mass index in the exercise group with
no observed changes in the control group. A randomized controlled trial by Hinderliter et al.
[230] demonstrated that six months of 55 minutes of endurance training (cycling, walking, or
jogging), where 20 minutes were designated for warming up and cooling down and 35 minutes
for exercise at 75-85% HRmax, three to four times per week, significantly reduced left ventricle
relative wall thickness and posterior wall thickness in 82 overweight subjects with high blood
pressure. Rinder et al. [231] compared the effects of six months of endurance exercise training
(brisk, walking, jogging, running, or cycling) three times per week at a progressive intensity (60
to 85% HRR) versus pharmacological treatment (hydrochlorothiazide) on LVH in 28 older adults
(mean age 65.9 years old) with high blood pressure. Their results suggested that exercise training
was as effective as drug treatment on LVH regression. Boman et al. [232] evaluated the left
ventricular structure and function between 212 sedentary hypertensive subjects, 236 hypertensive
subjects that exercised 30 minutes or less twice per week, and 510 hypertensive subjects who
exercised more than 30 minutes twice per week. They found a significantly lower left ventricle
mass, left ventricle mass indexed to height, and left ventricle wall thickness in both exercise
groups in comparison to the sedentary group. No differences were found in cardiac function
among the three groups. In a follow-up study, Palatini et al. [33] classified 454 hypertensive
subjects into sedentary, mild-exercisers, and exercisers cohorts according to a standardized
questionnaire assessing physical activity and compared the evolution of the cardiac structure by
echocardiography amongst groups. They observed that the exercise group had a reduced risk to
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develop LVH compared to the sedentary group. Pitsavos et al. [191] used a randomized
controlled study to examine the effects of 16 weeks of cycling during ~45 minutes at 60-80
HRmax three times per week on LVH development in 40 adults with high blood pressure (mean
age 53.5 years old). They observed a significant reduction in the left ventricle mass index over
the duration of the study. Zheng et al. [233] in a randomized controlled trial, compared the
effects of six months of cycling during 30 minutes at the first ventilatory threshold three times
per week on ventricular function in 50 hypertensive patients. They described an improvement in
left ventricular diastolic function measured by left atrial volume index, peak mitral filling
velocities during early (E) and late (A) diastole E/A ratio, deceleration time of the mitral E wave,
and tissue Doppler Ea/Aa ratio in the exercise group. Andersen et al. [234] found in a
randomized controlled study that 6 months of 60-minute soccer training twice per week in 31
hypertensive adults (mean age 46 years old) significantly improved diastolic function and did not
enhance LVH. Conversely, two prospective studies [235,236] did not observe changes in LV
dimensions, LV mass, or diastolic function after 6 months of endurance exercise training in 15
individuals with high blood pressure or after ~16 months of endurance exercise training in 32
individuals with high blood pressure, respectively. To date, there is no clinical evidence
regarding the effects of resistance training on the heart of individuals with high blood pressure
[226]. Additionally, multiple studies have indicated that exercise training benefits the heart by
reducing peripheral resistance, reducing resting heart rate, improving contractility, increasing the
diameter of the coronary arteries, and favoring collateral coronary circulation growth
[226,228,237,238].
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2.4.4.8. Vascular Adaptations
Exercise-induced vascular functional and structural adaptations have been extensively
reported in healthy and CVD individuals [21,239]. These adaptations are vessel specific (e.g.
elastic, conduit, and resistance arteries) [21] and go beyond those vessels that supply blood to
contracting muscles (e.g. carotid artery) [240,241].
Favorable functional adaptations have been described through improvements in flowmediated dilation (FMD) in individuals with high blood pressure [167,242]. As an illustration,
Nualnim et al. [243] performed a 12-week intervention where they compared FMD before and
after swimming training (45 minutes, 70-75% HRmax, 3-4 times per week) or relaxation exercises
in 43 individuals with high blood pressure. They observed a 2.2-fold significant increase in FMD
in the swimming group. Westhoff et al. [244] also showed a significant improvement in FMD
wtihin individuals with high blood pressure that completed a 12-week treadmill program at blood
lactate leves of 2.5 (0.5) mmol/L during 30 to 36 minutes. To compare the effects of exercise
modalities on FMD, Beck et al. [215] randomly allocated 43 individuals with high blood
pressure to either a resistance training, walking/running training, or control group. Both exercise
modalities showed a significant improvement in FMD in comparison to the control group, but no
appreciable differences were observed between the two exercise modalities. Additionally, to
evaluate the effects of exercise duration on FMD, Swift et al. [245] compared the evolution in
FMD after 6-month of endurance training at 50% HRmax three times per week in 155 obese
postmenopausal women with high blood pressure. Subjects were randomly assigned to complete
4, 8, or 12 kilocalories per kilogram of energy expenditure per week or to a no exercise control
group. All three exercise groups showed significant improvements in FMD compared to the
control group, but no significant statistical differences were found among the exercise groups.
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Further, to compare the effects of exercise intensity on FMD, Molmen-Hansen et al. [192]
randomly assigned 88 high blood pressure patients to 12 weeks of HIIT, moderate-intensity
endurance training, or to a control group. They reported a significantly increase in FMD within
the HIIT group only. In contrast, Westhoff et al. [185] did not find any changes in FMD in
individuals with high blood pressure after 12-weeks of 24-30 minutes of upper body exercise
(arm-cranking) at blood lactate levels of 2.0 (0.5) mmol/L, three times per week.
The classic approach to evaluate vascular structural adaptations is to analyze arterial
diameter, wall thickness, or peak blood flow measured by plethysmography [21]. The latter
reflects the ceiling structural capacity of the vessels. As examples, Higashi et al. [167] and Beck
et al. [246] demonstrated improvements in forearm blood flow in individuals with high blood
pressure after 12-weeks of endurance training and 8 weeks of resistance training, respectively,
which indicates an structural improvement in resistance vessels.

2.4.4.9. Inflammation
Exercise training has the potential to reduce levels of CRP and IL-6 in both healthy and
diseased individuals [247,248]. However, limited evidence exists regarding the effects of
exercise on inflammation in individuals with high blood pressure. Lamina et al. [249] in a
randomized controlled trial, reported that eight weeks of interval cycling at 60-79% HRmax for
45-60 minutes significantly reduced CRP in 140 individuals with high blood pressure compared
to a sedentary control group composed of 105 individuals with high blood pressure.
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2.4.4.10. Oxidative Stress
The effects of exercise on oxidative stress have been studied more extensively in animal
hypertensive models than in humans [250,251]. Only a few clinical studies have explored the
relationship between chronic exercise in individuals with high blood pressure and oxidative
stress biomarkers. Feairheller et al. [252] evaluated the changes in urinary 8-iso-prostaglandin
F2α (8-iso-PGF2α), urinary nitric oxide metabolites, and plasma total antioxidant capacity (TAC)
in 94 sedentary individuals with high blood pressure after 6 months of endurance training three
times per week at 70% VO2max. They found significant increases in both 8-iso-PGF2α and TAC
levels with a concurrent significant decrease in nitric oxide metabolites, which might indicate
improvements in antioxidant capacity. Beck et al. [246] randomly assigned 43 young adults with
high blood pressure into three groups (resistance training, endurance training, and control) and
analyzed pre- and post- antioxidant capacity and lipid peroxidation in an eight-week trial. Both
exercise groups significantly increased plasma antioxidant capacity and significantly reduced 8iso-PGF2α plasma levels. Dantas et al. [253] evaluated the effects of 10-week resistance training
on oxidative stress in 25 elderly women with high blood pressure in a randomized, controlled
trial. They described significantly increased levels of plasma TAC and a significant reduction in
plasma malondialdehyde (MDA).

2.4.5. The Endothelium and Atherosclerosis
The endothelium is an active metabolic barrier between that can locally modulate the
vascular tone and the immune, thrombotic, and inflammatory responses [254]. Each endothelial
cell is surrounded by a plasma membrane with specific receptors (e.g., glycocalyx, ion channels,
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receptor-tyrosine kinases) to sense changes in shear stress. Those receptors in turn transmit a
signal to the nucleus through mechanotransduction of the cytoskeleton [255].
The endothelium can be considered as one of the most important endocrine glands in the
body. In direct contact with the blood, endothelial cells can release several soluble factors that can
regulate blood flow, hemostasis, vascular tone, inflammation, angiogenesis, the immune system,
and other specific functions. From a practical standpoint, these soluble factors can be divided
according to their function [256-258]:
Vascular Tone
-

The endothelial nitric oxide synthase (eNOS) catalyzes the production of NO from Larginine. The enzyme is activated via changes in intracellular calcium in response to shear
stress patterns or via a receptor-mediated process (e.g. acetylcholine, bradikinine).
Released NO activates guanylate cyclase in smooth muscle cells, converting GTP to
cGMP. This activates a protein kinase that inhibits the influx of Ca2+ into the smooth
muscle, which in turn decrease the binding between calcium and calmodulin producing a
decrease in the phosphorylation of myosin and further in smooth muscle tension
(vasodilatation).

-

Leukotrienes are synthesized from arachidonic acid. They produce vasoconstriction and
have effects on increasing permeability, adherence, and chemotaxis. Endothelial cells do
not contain 5-lipoxygenase, so they interact with neutrophils to metabolize leukotrienes.

-

Prostacyclin is also synthesized from arachidonic acid by endothelial cells in response to
inflammatory mediators, like interleukin-1 (IL-1) that acts as a vasodilator and inhibits
platelet aggregation and thrombosis.
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-

Endotehlin-1 (ET-1). ET-1 binds to vascular smooth muscle receptors and produce
vasoconstriction. In addition, ET-1 stimulates smooth muscle cell proliferation.

Immune System and Inflammation
-

Chemokines (α and β chemokines and fractalkine) are produced in processes like
inflammation and cancer. They have anti-inflammatory properties by releasing decoy
receptors for TNF-α and IL-1.

-

Adhesion molecules. Endothelial cells mediate the adhesion of leucocytes expressing in
their surface E-selection, P-selectin, intercellular adhesion molecule-1 (ICAM-1) and
vascular cell adhesion molecule (VCAM). Their expression can be upregulated by
inflammatory cytokines. Platelet activating factor (PAF) also upregulate adhesion factors
for leucocytes and platelets. The mechanisms involve interaction of the platelet
glycoprotein IIb/IIIa with fibrinogen and endothelial vitronectin receptors.

Hemostasis and Coagulation
-

von Willebrand factor (vWF). vWF is a protein stored in the Weibel–Palade bodies of
endothelial cells. They have a role in platelet recruitment and thrombus formation. vWF is
released into the blood stream where it stabilizes factor VIII and is associated with collagen
VI in the sub-endothelium.

-

Lipid mediator platelet-activating factor (PAF). PAF promotes the activation of platelets
and their adhesion to the endothelial cells.

-

Thromboxane A2 (TXA2). TXA2 has prothrombotic properties and is a potent
vasoconstrictor.

-

Tissue Factor (TF). TF initiates coagulation by binding to factor VIIa.
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Angiogenesis
-

Vascular endothelial growth factor (VEGF). These factors can induce the formation of new
vessels from the endothelium. Also, they contribute to the inflammatory response and
vascular tone by releasing adhesion molecules and NO, respectively.

Fibrinolysis
-

Tissue-type plasminogen activator (t-PA). t-PA catalyzes the conversion of plasminogen
to plasmin, which is responsible for clot breakdown.

Atherosclerosis is a vascular condition characterized by a defective endothelium, chronic
inflammation, oxidative stress exacerbation and the formation of a waxy substance inside the inner
layer of large and medium-sized arteries known as plaque [259,260]. A plaque is filled with lipids,
calcium, debris, inflammatory cytokines, and ROS [261]. Atherosclerosis is the first cause of death
worldwide and can lead to catastrophic cardiovascular diseases like coronary artery disease, stroke,
heart failure, and peripheral artery disease [1].
According to the most current theory, the physiopathology of atherosclerosis involves 3
stages: fatty streak formation, plaque progression, and plaque disruption [262]. The buildup of a
plaque starts in the first decades of life with the accumulation of fatty streaks inside the inner
portion of an artery. Four cellular mechanisms have been identified: endothelial dysfunction,
lipoprotein entry and modification, leukocyte recruitment, and foam cell formation [260,263].
Endothelial dysfunction is considered the first step in plaque development. An initial trauma to the
endothelium is necessary to trigger a disturbance in its metabolic balance to maintain homeostasis.
This trauma can be originated due to a decrease mechanical stimulus provided by ESS, an increase
in cyclic stretch due to high blood pressure, and/or by a chemical toxic environment. A reduction
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in endothelial shear stress is associated with plaque development (e.g. branches of arteries) and
that blood flow patterns can also modulate this process (e.g. oscillatory blood flow upregulates
pro-atherogenic genes and downregulate anti-atherogenic genes) [69]. An increase on sustained
cyclic stretch have been reported to be involved in every stage of plaque development (e.g.
infiltration of LDL inside the wall, expression of adhesion molecules and scavenger receptors, and
metalloproteinases production). Regarding chemical stimulus, increased levels of glycemia, lipids
(TG, LDL-C, VLDL-C), or tobacco-related substances can interact with endothelial cells and can
boost the ROS production and trigger several inflammatory pathways. Once the endothelium
cannot act as an effective barrier for the circulatory factors, LDL-C enters the intima, binds to
proteoglycans and starts accumulating in the sub-endothelial space. Several modifications to LDLC structure (e.g. oxidation, glycation) promotes an inflammatory cycle, expression of leukocytes
adhesion molecules, and foam cell formation. Then, the expression of adhesion molecules (e.g.
VCAM-1, ICAM-1, E-selectin, P-selectin) in the apical part of endothelial cells attract monocytes
and T lymphocytes to the site of injury. In addition, chemoattractant signals (e.g. MCP-1) induce
direct diapedesis of these leukocytes into the sub-endothelial space. Simultaneously, inflammatory
cytokines (e.g. TNF-α, IL-1), ROS, tissue factor, matrix metalloproteinases, and platelet derived
growth factor (PDGF) are released by monocytes while T lymphocytes deregulate the adaptive
immune response. Next, monocytes are differentiated into macrophages with scavenger receptors
that detect and internalize modified LDL-C. This process is not controlled by inhibitory feedback,
so large amounts of modify LDL will start to accumulate inside the macrophages giving them a
foam-like appearance. Foam cells then release more inflammatory cytokines while some of them
enter in apoptosis and generate debris. Further accumulation of foam cells, debris, and lipids forms
the center of the plaque as it continues to progress due to the migration of smooth muscle cells

47

from the media to the intima layer promoted by inflammatory cytokines and PDGF. Smooth
muscle cells also start producing more collagen matrix that surrounds the core resulting in a mature
fibrous plaque. Finally, smooth muscle cells release matrix metalloproteinases which degrade
small portions of the fibrous cap, leading to micro ruptures, thrombi activation, and plaque
disruption [264].

2.4.6. Exercise-Induced Blood Flow Patterns
More than 50% of the cardiovascular benefits of exercise are explained by an underlying
mechanism different than the reduction of risk factors [20]. During exercise, cardiac output
increases that, in turn, produces a rise in ESS [21]. Depending on the intensity of the exercise, a
transition from laminar to turbulent flow can be observed [68]. This hemodynamic stimulus has
shown to induce anti-atherogenic adaptations on the vasculature that contribute to the reduction
of CVD [21,23,265]. In vitro cellular and in vivo animal studies have been commonly employed
to describe changes on gene expression of endothelial cells exposed to shear stress and more than
3,000 endothelial genes have been identified to be affected by an increase in ESS [266].
Classically, studies have reported an upregulation of eNOS, phosphorylation of eNOS serine1177 by Akt, an upregulation of SOD, and a down regulation of adhesive proteins (e.g. VCAM1, ICAM-1) following an exposure of a minimum of 6 hours of high-ESS [23,34,66,266-273].
Regarding blood flow patterns, the most common finding has been that oscillatory blood flow
induces an upregulation of atherogenic genes and a downregulation of anti-atherogenic genes on
endothelial cells in comparison to anterograde laminar flow [23].
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2.4.7. Summary
In summary, the endothelium has a key role in the development and maintenance of high
blood pressure and atherosclerosis. Exercise training can favor the balance of endothelial
function towards a healthier endothelium phenotype in individuals with high blood pressure,
which in turn improve cardiovascular risk factors and health outcomes. For individuals with
elevated blood pressure or stage 1 hypertension, exercise training is a recommendation class IA
[7]. However, only 21.6% of the US adult population fulfill the minimal requirements of daily
physical activity [1] and a large dropout rate has been described in cardiac rehabilitation
programs [35]. The incorporation of nontraditional modalities of exercise that are supported by
scientific evidence is an attractive idea to overcome these issues. Therefore, boxing training as a
nontraditional form of exercise that combines endurance, coordination, and strength in an
enjoyable environment could improve the health of individuals with elevated blood pressure or
stage 1 hypertension by reversing several pathological pathways involved with high blood
pressure, such as endothelial dysfunction, inflammation, oxidative stress, arterial stiffness, and
low-ESS.
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CHAPTER 3: METHODS
3.1. Experiment 1: Randomized Controlled Trial
3.1.1. Participants
Participants were recruited from the University of Texas at El Paso and its surroundings.
They were identified by a preliminary blood pressure screening and a health questionnaire. The
cohort consisted of subjects who met the following inclusion criteria: (1) ≥18 years old, (2) SBP
between 120-139 mmHg and/or DBP between 80-89 mmHg obtained from 2 different days, (3)
an estimated 10-year risk of CVD ≤10%, calculated by the ACC/AHA Pooled Cohort Equations,
and (4) no current participation in 3 or more days per week of endurance or resistance exercise
training. Exclusion criteria included non-controlled cardiac, pulmonary, or metabolic diseases,
smoking, consumption of nutritional supplements containing antioxidants, and any physical
impairment to exercise.

3.1.2. Protocol
The study was a double-blind (both evaluator and participant) randomized, controlled
trial. Figure 1 describes the protocol for Experiment 1. An initial brachial blood pressure
screening was performed to identify potential participants for the present study. Those with SBP
readings between 120-139 mmHg or DBP between 80-89 mmHg were instructed to report to the
Clinical Applied Physiology Lab at The University of Texas at El Paso having fasted for a
second blood pressure assessment, to confirm the diagnosis of elevated blood pressure or stage 1
hypertension. Then, participants were asked to complete a health questionnaire to rule out any
cardiac, pulmonary, or metabolic condition. Once they were cleared to participate, participants
started the informed consent process (UTEP IRB Study Number 1364179-3). After obtaining the
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consent, their height and weight were measured using a stadiometer (Seca 225, Seca Medical
Measuring Systems and Scales, Hamburg, Germany) and a digital scale (Tanita WB-110A,
Tanita Corporation, Tokyo, Japan), respectively. Thereafter, participants were asked to lay down
in supine position over an examination table for 10 minutes where PWA (Sphygmocor, Xcel,
West Ryde, Australia), PWV (Sphygmocor, Xcel, West Ryde, Australia), carotid ultrasound
imaging, brachial and popliteal FMD, and strain gauge venous occlusion plethysmography (AI6
Arterial Inflow System, D.E. Hokanson Inc., Bellevue, Washington) were performed from the
right side of their body. At the end of the first lab visit, they completed the SF-36 questionnaire
and were asked to comply with a low nitrate diet for 48 hours. In a second visit, a catheter was
placed in the antecubital vein of the participants to collect blood samples, followed by a body
composition analysis through dual-energy X-ray absorptiometry (DXA) (Lunar Prodigy, GE
Healthcare, Madison, WI), an echocardiographic assessment to determine cardiac dimensions
and function (MyLab 25Gold, Esaote, Firenze, Italy), and a cardiopulmonary test using a crankarm ergometer (Angio V2, Lode, Groningen, Netherlands) to determine their VO2max
(Parvomedics Inc., Sandy, UT) and their ventilatory and lactate thresholds (Lactate Plus, Nova
Inc., Boston, MA). Participants were then randomly assigned by a member of the research team
who was not involved in the assessments or the analysis into a boxing or a control group using an
online number generator (https://www.graphpad.com/quickcalcs/randomize1/). Participants were
unaware of the allocation possibilities. A 6-week intervention was designed for each group. Each
intervention was supervised by members of the research team who were not involved in the
assessments or the analysis. Finally, all the measurements taken in the first two visits were
repeated in the same order at the end of the intervention. The evaluator who performed the preand post- assessments was blinded to the allocation of each participant.
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Figure 1. Experiment 1 protocol design.

3.1.3. Interventions
3.1.3.1. Boxing Training
First, in a familiarization visit, participants learned how to wrap their hands and perform
basic boxing techniques such as stance and punches while wearing 14-oz gloves. This visit
finished with an incremental boxing test that consisted of punching a 100 lb heavy bag (Ringside
soft filled leather, Ringside-CSI Fitness 1st, Lenexa, KS) at a fixed force (~20 kg) and with an
increase in the punching cadence every 3 minutes. The force was tracked by a sensor attached to
the bottom of the heavy bag (UFC Force Tracker) which via a phone app (XFORCE tracker,
SEROSE) gave visual feedback of power and rhythm to the participant. The test started at a
cadence of 140 punches per minute (ppm) controlled by a metronome (Pro Metronome by
EUMLab, Xanin Tech. GmbH.) and was increased 30 ppm every 3 minutes, until fatigue.
Fatigue was determined when participants were not able to maintain the punching tempo and
they were asked for a 1-minute all-out to finish the test. As depicted in Figure 2, oxygen uptake
(VO2), heart rate (HR), blood lactate, and rate of perceived exertion (RPE) were measured at the
end of each 3-minute workload.
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Figure 2. Incremental boxing test design.
HR: heart rate, VO2: oxygen uptake, RPE: rate of perceived exertion
The boxing training intervention consisted of three exercise sessions per week on
nonconsecutive days for six weeks. The workout begun with a 3-minute warm up period where
participants actively move their shoulders, elbows, wrists, and finger joints. Participants were
then instructed to complete 10 rounds of three minutes with one-minute resting period
interspersed as displayed in Figure 3. During the rounds, participants punched a heavy bag (e.g.
straight, jab, hook) or did mitt work. The intensity of seven of those rounds was set below their
ventilatory and lactate thresholds at approximately 60% HRR or less than 4 on the modified RPE
scale (1-10). The intensity of the remaining 3 rounds was set at 90-95% VO2max and at
approximately 95% HRR. Heart rate and RPE were constantly monitored to ensure that each
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participant was exercising at the desired intensity. Weekly training characteristics are presented
in Appendix A.

Figure 3. Boxing workout design.

3.1.3.2. Flexibility and Balance Training (Control)
The control group performed 10 minutes of dynamic articular movement, five minutes of
unipedal stance, and five minutes of stretching of the upper limbs three days per week for six
weeks.

3.1.4. Measurements
3.1.4.1. Brachial Blood Pressure and Heart Rate
Blood pressure assessments were performed according to the ACC/AHA
recommendations [7]. Briefly, participants seated in a chair for five minutes with their feet on the
floor and their back supported, followed by the recording of blood pressure and resting heart rate
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in triplicate with a validated automated brachial blood pressure cuff (BP760, Omnron
Healthcare, Inc., Lake Forest, IL).

3.1.4.2. Central Blood Pressure
A cuff-based device for PWA (Sphygmocor Xcel, AtCor Medical, West Ryde, Australia)
was attached to the right arm of every participant in supine position after 10 minutes of resting.
Each PWA assessment lasted between 60 and 120 seconds: 50-110 seconds to record brachial
blood pressure and 10 seconds of sub-diastolic recordings. Central blood pressure waveforms
were generated by a validated transfer function [274]. According to manufacturer’s
recommendations, the blood pressure waveforms were considered acceptable if the overall
quality control indices were equal to or above 75%.
The following PWA variables were assessed: cSBP, cDBP, cPP, AIx, and AIx@75.
cSBP and cDBP are the estimated blood pressures at the ascendant aortic wall during systole and
diastole, respectively. cPP is the difference between cSBP and cDBP. AIx is the ratio between
the increase in aortic blood pressure produced by reflected waves in relation to cPP and AIX@75
is the normalization of AIx to 75 bpm [275]. All these variables have been associated with
cardiovascular risk [276]. Additionally, Wasted Left Ventricle Energy (LVEW), a surrogate for
left ventricle work and myocardial oxygen demand, was estimated from the pulse pressure curve
and the duration of the reflected wave. LVEW was calculated using the following formula: LVEW
= ((ED – Δtp) x (cSBP – Pi) π/4) x 1.33322, where ED is ejection duration, Δtp is time to arrival
of the reflected pressure wave, and Pi is the pressure at the first inflection point marking the
onset of reflected aortic pressure wave [277,278].
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3.1.4.3. Pulse Wave Velocity
Carotid-femoral pulse wave velocity (PWVcf) is considered the gold standard to
determine arterial stiffness [279]. For this procedure, participants were supine over an
examination table for 15 minutes and a cuff was placed in the right thigh. During this period,
carotid and femoral pulses were palpated. Then the following distances were measured using a
metallic tape: carotid to sternal notch, sternal notch to cuff, and femoral to cuff. Once the
participant reaches hemodynamic stability, a high-fidelity tonometer was placed over the carotid
artery. Pulse waves of the carotid and femoral arteries were simultaneously recorded by the
tonometer and the cuff, respectively. PWVcf was determined by dividing the distance obtained
through the subtractive method by the delay time between waves [96,280-282].

3.1.4.4. Cardiopulmonary Exercise Testing
An 8-to-12 minutes exercise test on a crank-arm ergometer was performed using the
AHA guidelines [119]. The test started at 50 watts (W) and 40 W for male and female
participants, respectively, with a 15 W increase for the former and 12 W for the latter, until
fatigue. A cadence of 60 rpm was maintained throughout the test. Oxygen uptake and heart rate
were continuously monitored. RPE and lactate were determined at the end of each workload. To
assess oxygen uptake, participants breathed through a mouthpiece connected via a long tube to
the metabolic cart and a nose-clip was placed on the participant’s nose to prevent air leakage.
Immediately before starting their exercise tests, the participant’ earlobe was poked with a microlancet to monitor lactate blood levels. VO2max was defined as the greatest value recorded during
the test when the participants accomplish at least three of the following criteria: (1) plateau in
oxygen uptake (e.g. <150 ml/min difference between workloads), (2) respiratory exchange ratio
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> 1.1, (3) ≥90% predicted maximal heart rate, and (4) blood lactate levels >6 mmol/L [283]. The
VO2max is expressed relative to body mass (ml/kg/min). The first ventilatory threshold and the
lactate threshold were determined by the V-slope [284] and the D-max methods [285],
respectively.

3.1.4.5. Echocardiography
A two-dimensional echocardiography study was performed according to the
recommendations of the American Society of Echocardiography [286,287]. Images were
obtained along the parasternal long and short axis, including the apical, subcostal, and
suprasternal views). From the parasternal long-axis view, end-diastolic measurements of the
septal wall thickness (IVSd)), left ventricle diameter (LVEDD), posterior wall thickness (PWd),
and left ventricular end-systolic diameter (LVESD) were obtained to estimate left ventricle
ejection fraction (LV EF%) and mass. The LV EF% was calculated as the ratio between LVESD
and LVESD. LV mass was estimated by Devereux formula: LV mass = 0.8 (1.04 [(LVEDD +
PWd + IVSd)3- (LVEDD)3])+ 0.6 g [288]. End-diastolic volume (EDV) and end-systolic volume
(ESV) of LV and Stroke Volume were calculated by the Simpson method from the apical 4chamber and 2-chamber views. Pulsed, continuous and color Doppler were used to evaluate
valvular function. Additionaly, lateral tisular Doppler velocity was assessed to evaluate LV
diastolic function. Finally, aortic measurements were made from a 2D parasternal long axis-view
using the inner edge-to-inner edge (I-I) convention at the Sinus of Valsalva [287,289].
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3.1.4.6. Body Composition Analysis
Total body and regional body composition were estimated through DXA. Before the
assessment, the equipment was calibrated according manufacturer’s instructions. The system
calculated the mass of lean soft tissue, fat, and bone mineral for the whole body, trunk, and
extremities. DXA is one of the preferred techniques to determine body composition [290].

3.1.4.7. Questionnaire to assess Quality of Life: SF-36
The short-form 36 (SF-36) was created in 1992 to evaluate health-relate quality of life
[291]. The SF-36 is a short survey that covers a total of 8 sub-dimensions related to physical and
mental health: (1) Physical Functioning, (2) Role Limitations due to Physical Problems, (3) Social
Functioning, (4) Bodily Pain, (5) General Mental Health, (6) Role Limitations due to Mental
Problems, (7) Vitality, and (8) General Health Perceptions. The SF-36 includes a diverse mixture
of continuous item scaling methods and is comprised of 10 items with balanced multi-item
response formats (range from 1 to 5), 7 items with a dichotomous response format (1 or 2), and 19
items with non-balanced multi-item response formats (nine items range from 1 to 3 and ten items
range from 1 to 6). To obtain the raw score for each sub-dimension, 10 items are reversed. Then,
raw values for each sub-dimension are summed. Finally, the raw scores are transformed to a 0-to100 scale for each sub-dimension [292]. The utility of the SF-36 has been explored in clinical trials
in selected groups suffering from physical or mental conditions. Patients with mental illnesses,
scored significantly lower in the mental health section in comparison to matched asymptomatic
controls. Also, in a 4-week follow-up study, symptoms of chronic cardiovascular conditions were
positively correlated with lower scores on the SF-36. In addition, the sub-dimensions of the SF-36
showed correlations above 0.9 with the 140-items Medical Outcome Study. The validity,
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reliability, and consistency of this questionnaire have been demonstrated in previous research
[293].

3.1.4.8. Endothelial Function Testing
3.1.4.8.1. Flow-Mediated Dilation (FMD)
For brachial FMD, participants were asked to lay down in a supine position over an
examination table for at least 10 minutes. A total of six electrodes were attached to their chest in
the standard lead II setting, where three electrodes were connected to a high-definition
ultrasound machine (MyLab30 Gold Cardiovascular, Esaote, Firenze, Italy) and the other three
were connected to an electrocardiogram trigger system (MP150WSW, BIOPAC Systems Inc.,
Goleta, CA and Frame Grabbing and Digital Data Input modules, Medical Imaging Applications
LLC, Coralville IA). The right arm was moved at 80-90° of shoulder abduction over an armrest
and a blood pressure cuff was attached to the forearm just below the antecubital fossa. A 12MHz linear phase array ultrasound transducer (LA435, Esaote, Firenze, Italy) with a transducer
holder (Patent pending, UTEP2019-006-PROV) was placed 5 cm above the antecubital fossa to
image the right brachial artery according to international guidelines for FMD [77,294,295]. Basal
artery diameters and peak systolic blood flow velocities were recorded in basal conditions at
every QRS complex captured by the electrocardiogram trigger system using an automated edgedetection software (Vascular Research Tools, Medical Imaging Applications LLC) for 30
seconds. Then, the forearm cuff was inflated to supra systolic pressure (>200 mmHg) for 5
minutes followed by the deflation of the cuff. Brachial artery diameters and blood flow velocities
were continuously registered every 3 seconds for 150 seconds, starting at 30 seconds before
deflation until 2 minutes after deflation using the automated edge-detection software. Peak
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diameters were identified as the single peak diameter observed during the plateau phase after
cuff deflation [296]. The reliability of FMD analysis in our lab has already been tested and is
described elsewhere [297]. For popliteal FMD, the same procedure is repeated but with the
difference that the cuff and the transducer were placed in the leg and in the popliteal fossa,
respectively. FMD was calculated as FMD% = 100 x (peak diameter – basal diameter)/basal
diameter [298].

3.1.4.8.2. Plethysmography
3.1.4.8.2.1. Forearm and Calf Blood Flow
Forearm blood flow (FBF) and calf blood flow (CBF) were assessed by strain gauge
venous occlusion plethysmography (AI6 Arterial Inflow System, D.E. Hokanson Inc., Bellevue,
Washington). Participants were in supine position over an examination table where strain gauges
were placed at the widest part of the right forearm or calf. Next, an upper-arm cuff for FBF and a
thigh cuff for CBF were cycled from 0 to 50 mmHg for seven seconds every 15 seconds to
prevent venous outflow. One minute before each measurement, a wrist and an ankle cuff were
inflated to 200 mmHg to occlude hand and ankle circulation, respectively. Absolute blood flow
was determined by the rate of change of limb circumference (e.g. slope) during the seven-second
venous occlusion. FBF and CBF were estimated as the average of three readings in a minute
[246].

3.1.4.8.2.2. Forearm and Calf Blood Flow during Reactive Hyperemia
FBF and CBF during reactive hyperemia was measured after five minutes of occlusion
of the arm or thigh, respectively. These measurements are a reliable non-invasive alternative to
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estimate endothelial function in resistance vessels [299]. Baseline FBF and CBF were recorded
for 2 min, then the respective cuff was inflated to 200 mmHg for five minutes and then rapidly
deflated. FBF and CBF was measured every 15 seconds for three minutes. Peak FBF and CBF
were selected from the highest value of blood flow following deflation of the cuff [246].

3.1.4.9. Carotid Artery Ultrasound
An 8-18 Hz ultrasound transducer (LA435, Esaote, Firenze, Italy) inserted into a neck
transducer holder was attached to the right side of the neck of each participant and the midsection of the common coronary artery was identified in a high-definition ultrasound machine
(MyLab30 Gold Cardiovascular, Esaote, Firenze, Italy). Resting arterial diameters and peak
systolic blood flow velocities were recorded continuously during 10 seconds at a rate of 10
frames per second using an automated edge-detection software (Vascular Research Tools,
Medical Imaging Applications LLC).
Resting ESS was estimated during 10 seconds by Womersley’s approximation, using
ESS = μ * SR and SR = 2K * V/D, where μ is blood viscosity, SR is shear rate, V is peak
systolic velocity, D is artery diameter, K is a complex factor dependent only on the Womersley
parameter (α), and α=(D/2)*(ω/(μ/ρ))1/2, where ω is the angular frequency of the flow pulsation
(ω=freq*2π), ρ is blood density, and μ is blood viscosity [300,301]. ESS is expressed in
dynes/cm2.
Blood viscosity and density were calculated using the following formulas [68,302,303]:
=
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.
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,

=

∗ exp (2.31+,-), and / = [1.09+,- + 1.035 ∗

(1 − +,-)] , where μplasma is plasma dynamic viscosity expressed in Pa·s, T is temperature
expressed in °C, and Hct is Hematocrit expressed as a fraction.
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3.1.4.10. Tissue Sampling
3.1.4.10.1. Blood Lactate
Blood lactate was taken via micro-sample from the earlobe and analyzed with an
automated lactate analyzer (Lactate Plus, Nova Inc., Boston, MA).

3.1.4.10.2. Hematocrit
Two blood samples were collected from the earlobe using micro-hematocrit capillary
tubes (Fisher Scientific, Pittsburgh, PA) and hematocrit readings were performed after
centrifugation (HemataStat II Hematocrit Analyzer, Separation Technology Inc., USA).

3.1.4.10.3. Antecubital Vein Blood Collection
After 48 hours of a low nitrate diet under fasting conditions, 20 ml blood samples were
obtained from the antecubital vein of each participant. Blood samples were immediately
centrifuged to obtain plasma samples, the latter being placed in aliquots at -80 °C until analysis.
NOx (Total Nitric Oxide and Nitrate/Nitrite Parameter Assay Kit, R&D Systems), lipid profile
(HDL and LDL/VLDL Cholesterol Assay Kit, ab65390, Abcam), CRP (C-Reactive Protein
(human) ELISA Kit, 10011236, Cayman), IL-6 (Interleukin-6 (human) ELISA Kit, 501030,
Cayman), TNF-α (TNF-α (human) ELISA Kit, 589201, Cayman), F2-isoprostanes (STAT-8isoprostane ELISA Kit, 500431, Cayman), TAC (Antioxidant Assay Kit, 709001, Cayman), and
SOD (Superoxide Dismutase Assay Kit, 706002, Cayman) were performed according the
manufacturer’s instructions for their respective kit at the core lab of the health sciences building
at UTEP.
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3.1.5. Statistical Analysis
Data was analyzed using SPSS version 24.0. Normal distribution of the data was
examined with the Shapiro-Wilk test and visual inspection. Independent t-tests were conducted
to compare demographic variables between groups. A repeated measure general linear model
(GLM) with two levels of time (pre and post) and using two groups (Boxing and Control) was
employed to compare between- and within-group differences. Fisher's Least Significant
Difference (LSD) was selected as the post hoc test and partial eta-squared effect size (η6 ) as the
indicator of effect size. η6 of 0.02, 0.13, and 0.26 were considered small, medium, and large
effects, respectively [304]. Significance was established at α ≤ 0.05. The sample size was
determined using the software G*Power 3.1. Based on Izadi et al. [193] results on the effects of
six weeks of HIIT on SBP (effect size = 1.73), establishing α at 0.05 and β at 0.2, and assuming a
30% drop out rate, the estimated number of participants per group was 12.

3.2. Experiment 2: Cross Sectional Study
3.2.1. Participants
Participants were recruited from the University of Texas at El Paso and its surroundings.
They were identified by a preliminary blood pressure screening and a health questionnaire. The
inclusion criteria consisted of: (1) ≥18 years old, (2) SBP between 120-139 mmHg or DBP
between 80-89 mmHg obtained from 2 different days, (3) an estimated 10-year risk of CVD
≤10%, calculated by the ACC/AHA Pooled Cohort Equations, and (4) no current participation in
3 or more days per week of endurance or resistance exercise training. Exclusion criteria included
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non-controlled cardiac, pulmonary, or metabolic diseases, smoking, consumption of nutritional
supplements containing antioxidants, and any physical impairment to exercise.

3.2.2. Protocol
First, height and weight were measured using a stadiometer (Seca 225, Seca Medical
Measuring Systems and Scales, Hamburg, Germany) and a digital scale (Tanita WB-110A,
Tanita Corporation, Tokyo, Japan), respectively. Next, blood samples were collected from the
earlobe using micro-hematocrit capillary tubes (Fisher Scientific, Pittsburgh, PA) followed by
centrifugation (HemataStat II Hematocrit Analyzer, Separation Technology Inc., USA) and
reading of their respective hematocrit values. Participants were asked to perform two boxing
evaluations. The first one was a maximal boxing test that determined VO2max and the lactate
threshold curve as described in Figure 2. The second one, performed at least 48 hours after the
first exercise test, consisted of two boxing rounds of three minutes with one-minute of rest in
between. During the first and second round, participants punched a 100 lb heavy bag at
60%VO2max and at 90-95% VO2max, respectively. Concurrently, diameter and blood flow
velocity from the common carotid artery were obtained through Doppler ultrasound at each
condition. In addition, measures of heart rate, oxygen uptake, blood lactate, and RPE were
obtained at the end of the third minute for each round.

3.2.3. Measurements
3.2.3.1. Carotid Artery Ultrasound Assessment
A total of six electrodes were attached to the chest of the participants in the standard lead
II setting: three electrodes were connected to a high-definition ultrasound machine (MyLab30
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Gold Cardiovascular, Esaote, Firenze, Italy) and the other three were connected to an
electrocardiogram trigger system (MP150WSW, BIOPAC Systems Inc., Goleta, CA and Frame
Grabbing and Digital Data Input modules, Medical Imaging Applications LLC, Coralville IA).
An 8-12 Hz ultrasound transducer (LA435, Esaote, Firenze, Italy) inserted into a neck transducer
holder was attached to the neck of the participants and the mid-section of the common carotid
artery identified. Artery diameters and peak systolic blood flow velocities were recorded
continuously using an automated edge-detection software (Vascular Research Tools, Medical
Imaging Applications LLC) at rest and during exercise as depicted in Figure 4.

Figure 4. Doppler-ultrasound of the common carotid artery during heavy bag punching.

3.2.3.2. Endothelial Shear Stress Calculations
ESS was estimated during 10 seconds by Womersley’s approximation, using ESS = μ *
SR and SR = 2K * V/D, where μ is blood viscosity, SR is shear rate, V is peak systolic velocity,
D is artery diameter, K is a complex factor dependent only on the Womersley parameter (α)
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where α=(D/2)*(ω/(μ/ρ))1/2, ω is the angular frequency of the flow pulsation (ω=freq*2π), ρ is
blood density, and μ is blood viscosity [300,301]. ESS is expressed in dynes/cm2.
Blood viscosity and density were calculated using the following formulas [68,302,303]:
=

[

.

]
"#

,

=

∗ exp (2.31+,-), and / = [1.09+,- + 1.035 ∗

(1 − +,-)] , where μplasma is plasma dynamic viscosity expressed in Pa·s, T is temperature
expressed in °C, and Hct is Hematocrit expressed as a fraction.

3.2.3.3. Blood Flow Patterns
Reynolds number (Re) is a dimensionless ratio of blood inertial forces to viscous forces.
For a given vessel geometry, Re determines whether the flow will be laminar or turbulent [305307]. Re was calculated using Re=(V*D* ρ)/ μ, where V is peak blood flow velocity, D is artery
diameter, ρ is blood density, and μ is blood viscosity [307]. To determine the onset of turbulence
under pulsatile flow conditions, peak Re critical was calculated using Repeak(cr)=169*α0.83*St-0.27,
where St is the Strouhal number St=freq*D*V and α is the Womersley parameter [308].

3.2.4. Statistical Analysis
Data was analyzed using SPSS version 24.0. Normal distribution of the data was
examined with the Shapiro-Wilk test and visual inspection. The assumption of sphericity was
evaluated by Mauchly’s test and corrected by the Greenhouse-Geisser method when it was
necessary. To compare ESS between resting and the two exercise conditions, a one-way repeated
measures ANOVA with Fisher´s LSD as post-hoc analysis was employed. Significance was
established at α ≤ 0.05. Effect size was determined by Cohen’s d, where 0.2 is a small effect size,
0.5 is a medium effect size, and 0.8 is a large effect size [309]. According to our preliminary data
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in cycling, a η6 of 0.948 was obtained for exercise-induced ESS in the carotid artery at three
exercise intensities. Using G*Power at a level of significance of 0.05 with a power of 0.8, the
minimum number of participants that is required was eight. Assuming a 30% drop out rate, the
estimated number of participants required was 10.
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CHAPTER 4: RESULTS
4.1. Experiment 1: Randomized Controlled Trial
4.1.1. Participants
Initially, 38 individuals were assessed for eligibility from June to August of 2019.
Fourteen subjects were excluded because their blood pressure did not meet the inclusion criteria.
As Figure 5 exhibits, a total of 24 participants were randomly allocated to one of the two groups.
Only 1 participant was lost for follow up assessments in the control group, leaving 12
participants in the boxing group and 11 participants in the control group that were finally
analyzed. All analyzed participants were college students.

Figure 5. Flow chart of participants.
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All variables were normally distributed except for age. All data is presented as mean and
standard deviation, unless otherwise stated. The baseline demographic characteristics of both
groups are summarized in Table 4. No difference was found between groups regarding age (U =
86.0, p = 0.235), height (t(21) = 0.39, p = 0.698), weight (t(21) = 0.78, p = 0.442), hematocrit
(t(21) = -0.06, p = 0.953), systolic blood pressure (t(21) = -0.98, p = 0.339), and diastolic blood
pressure (t(21) = -0.301, p = 0.766) before the intervention.

Table 4. Demographic characteristics of the participants.

Male

Boxing Training
Female

Total

Male

Control
Female

Total

n=8

n=4

N = 12

n=7

n=4

N = 11

Age (y)

27.6 (6.7)

23.5 (0.6)

26.3 (5.7)

26.0 (4.9)

22.0 (0.8)

24.6 (4.3)

0.235

Height (m)

1.7 (0.1)

1.5 (0.1)

1.7 (0.1)

1.7 (0.1)

1.6 (0.1)

1.7 (0.1)

0.698

Weight (kg)

97.7 (24.9)

72.4 (17.9)

89.3 (25.2)

100.6 (17.9)

88.8 (11.7)

96.3 (16.4)

0.442

Hct (%)

49.3 (3.4)

46.0 (3.3)

48.0 (3.7)

49.0 (2.9)

46.0 (4.2)

47.9 (3.5)

0.953

SBP (mmHg)

130.0 (7.2)

113.3 (4.6)

124.4 (10.3)

124.7 (13.3)

110.0 (11.8)

119.4 (14.3)

0.339

DBP (mmHg)

84.9 (6.1)

83.8 (2.5)

84.5 (5.1)

83.9 (4.7)

84.0 (4.1)

83.9 (4.2)

0.766

P

Data expressed as mean (SD). Hct: Hematocrit; SBP: systolic blood pressure; DBP: diastolic blood pressure.

Compliance to the boxing training protocol was 98.1%. Overall, 95.4% and 100% of the
target heart rates were sustained during the three high-intensity rounds and the seven lowintensity rounds, respectively. Additionally, participants reported a mean RPE of 8.3 and 2.8 for
the high-intensity and low-intensity rounds, respectively (Figure 6). Meanwhile, the compliance
to the flexibility and balance training was 27.3% in the control group.
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Figure 6. Heart rate and rate of perceived exertion during boxing training expressed as mean (SD). a)
Heart rate during boxing training. 95% CI of the target heart rate for each round are represented as dashed
lines; b) Rate of perceived exertion at the end of each round. RPE: rate of perceived exertion, bpm: beats
per minute.

No adverse cardiovascular effects were reported throughout the intervention. Meanwhile,
3 participants experienced anterior shoulder tenderness when punching during the first week of
training that was relieved in the subsequent weeks.

4.1.2. Blood Pressure
Significant group x time interactions were observed for SBP (F(1,21) = 32.34, p < 0.001)
and DBP (F(1,21) = 39.54, p < 0.001). No differences were observed in SBP (F(1,21) = 0.96, p =
0.339) and DBP (F(1,21) = 0.09, p = 0.766) between groups at baseline.
Six weeks of boxing training largely decreased systolic blood pressure (F(1,21) = 48.89,
p < 0.001, η6 = 0.700) and diastolic blood pressure (F(1,21) = 78.48, p < 0.001, η6 = 0.789) in
individuals with elevated blood pressure and stage 1 hypertension. Additionally, there was a
significant reduction in diastolic blood pressure (F(1,21) = 19.03, p = 0.001, η6 = 0.475) after the
intervention in the boxing group compared to the control group. No differences were found
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before and after the intervention in the control group regarding systolic blood pressure (F(1,21) =
1.39, p = 0.252, η6 = 0.062) and diastolic blood pressure (F(1,21) = 0.05, p = 0.825, η6 = 0.002)
(Table 5 and Figure 7).

Table 5. Brachial blood pressure changes following 6 weeks of intervention.
Boxing Training

Control
2

Before

After

Δ

P

ηp

Before

After

Δ

p

η2p

SBP
(mmHg)

124.4
(10.3)

108.4
(7.7)

-16.0

<0.001

0.700

119.4
(14.3)

122.2
(13.5)

2.8

0.252

0.062

DBP
(mmHg)

84.5
(5.1)

74.2
(5.0)

-10.3

<0.001

0.789

83.9
(4.3)

84.2
(6.0)

0.3

0.825

0.002

Data expressed as mean (SD). SBP: systolic blood pressure; DBP: diastolic blood pressure

Figure 7. Box plots of brachial blood pressure changes after boxing training. a) Systolic blood pressure; b) Diastolic
blood pressure. *** p < 0.001 ** p < 0.01
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4.1.3. Pulse Wave Analysis
Significant group x time interactions were only observed for cSBP (F(1,21) = 4.29, p =
0.05). Meanwhile, there were no significant interactions for cDBP (F(1,21) = 1.52, p = 0.231),
cPP (F(1,21) = 0.52, p = 0.479), AIx (F(1,21) = 1.06, p = 0.314), AIx@75 (F(1,21) = 0.20, p =
0.658), and LVEw (F(1,21) = 0.46, p = 0.504). No differences were observed in cSBP (F(1,21) =
0.02, p = 0.896), cDBP (F(1,21) = 0.22, p = 0.646), cPP (F(1,21) = 0.59, p = 0.451), AIx (F(1,21)
= 0.16, p = 0.694), AIx@75 (F(1,21) = 0.83, p = 0.373), and LVEw (F(1,21) = 0.77, p = 0.390)
between groups at baseline. A large reduction in cSBP (F(1,21) = 13.15, p = 0.002, η6 = 0.385)
was observed in the boxing training group following the intervention (Table 6 and Figure 8).
Additionally, no significant group x time interaction was detected in the duration of the reflected
wave (F(1,21) = 2.99, p = 0.098).

Table 6. Central blood pressure changes following 6 weeks of intervention.
Boxing Training
Before
After
Δ

Before

Control
After

Δ

Interaction
p

Group
p

Time
p

cSBP
(mmHg)

114.5
(10.7)

106.5
(6.3)

-8.0

113.9
(11.0)

112.5
(10.0)

-1.4

0.050

0.476

0.008

cDBP
(mmHg)

80.8
(9.0)

75.7
(8.0)

-5.1

79.0
(9.7)

77.2
(11.2)

-1.8

0.231

0.972

0.020

cPP
(mmHg)

33.6
(4.1)

31.0
(3.6)

-2.6

34.8
(3.3)

33.8
(7.1)

-1.0

0.479

0.207

0.129

AIx
(%)

15.0
(10.3)

5.6
(17.4)

-9.4

16.8
(12.1)

13.5
(7.0)

-3.3

0.314

0.271

0.040

AIx@75
(%)

12.3
(11.6)

3.3
(17.3)

-9.0

16.9
(12.7)

10.4
(7.4)

-6.5

0.658

0.213

0.011

LVEW
(dynes/s/cm2)

1217.5
(509.1)

764.9
(606.1)

-452.6

1422.0
(607.5)

1132.6
(415.0)

-289.4

0.504

0.150

0.006

Data expressed as mean (SD). cSBP: central systolic blood pressure; cDBP: central diastolic blood pressure; cPP: pulse pressure;
AIx: augmentation index; AIx@75: augmentation index at 75 beats per minute; LVEW: left ventricle energy wasted.
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Figure 8. Box plots of central blood pressure changes after boxing training. a) Central systolic blood
pressure (cSBP); b) Central diastolic blood pressure (cDBP). * p < 0.05

4.1.4. Arterial Stiffness
There was no significant group x time interaction for PWVcf (F(1,21) = 0.30, p = 0.096).
PWVcf was similar between groups at baseline (F(1,21) = 0.38, p = 0.545) and post training
(ANOVA DATA) (Figure 9).

Figure 9. Box plots of Pulse Wave Velocity before and after the intervention.
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4.1.5. Cardiorespiratory Fitness
Significant group x time interactions were observed for VO2max (F(1,21) = 60.08, p <
0.001), power output (F(1,21) = 27.67, p < 0.001), lactate threshold (F(1,21) = 15.59, p = 0.001),
and ventilatory threshold (F(1,21) = 14.91, p = 0.001). No differences were observed in VO2max
(F(1,21) < 0.01, p = 0.964), power output (F(1,21) = 0.28, p = 0.601), ventilatory threshold
(F(1,21) = 3.51, p = 0.075), and lactate threshold (F(1,21) = 2.04, p = 0.168) between groups at
baseline. Six weeks of boxing training led to a large increase in VO2max (F(1,21) = 70.17, p <
0.001, η6 = 0.770), power output (F(1,21) = 31.11, p < 0.001, η6 = 0.597), ventilatory threshold
(F(1,21) = 26.53, p < 0.001, η6 = 0.558), and lactate threshold (F(1,21) = 20.92, p < 0.001, η6 =
0.499). Meanwhile, a significant large reduction in VO2max (F(1,21) = 7.35, p = 0.013, η6 =
0.259) was observed in the control group at the end of the intervention (Table 7 and Figure 10).

Table 7. Changes on exercise capacity following 6 weeks of intervention.

Before

Boxing Training
After
Δ
P

η2p

Before

After

Control
Δ

p

η2p

VO2max
(ml/kg/min)

20.3
(5.1)

26.8
(5.8)

6.5

<0.001 0.770

20.4
(5.2)

18.2
(5.4)

Lactate
Threshold (W)

71.0
(22.2)

87.1
(23.6)

16.1

<0.001 0.499

87.2
(31.7)

83.2 -4.0 0.289 0.053
(25.2)

Ventilatory
Threshold
(%VO2max)

49.7
(9.3)

64.2
(11.2)

14.5

<0.001 0.558

59.4
(15.0)

58.2 -1.2 0.682 0.008
(15.8)

Power Output
(W)

95.0
(27.6)

110.0
(29.2)

15.0

<0.001 0.597

102.3
(37.8)

96.8 -5.5 0.066 0.152
(30.7)

Data expressed as mean (SD). VO2max: maximum oxygen uptake; W: watts.
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-2.2 0.013 0.259

Figure 10. Box plots of exercise capacity changes after boxing training. a) Maximum oxygen
uptake (VO2max); b) Power Output; c) Lactate Threshold; d) Ventilatory Threshold.
** p < 0.01, * p < 0.05.
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4.1.6. Cardiac Adaptations
Significant group x time interactions were observed for resting heart rate (F(1,21) =
22.60, p < 0.001). No differences were observed in heart rate between groups at baseline (F(1,21)
= 0.02, p = 0.890). Six weeks of boxing training largely decreased resting heart rate (F(1,21) =
32.81, p < 0.001, η6 = 0.610) in individuals with elevated blood pressure and stage 1
hypertension. Additionally, there was a significant reduction in resting heart rate (F(1,21) =
11.79, p = 0.002, η6 = 0.360) after the intervention in the boxing group compared to the control
group. No differences were found before and after the intervention in the control group regarding
resting heart rate (F(1,21) = 1.20, p = 0.285, η6 = 0.054) (Figure 11).

✱✱
✱✱

Figure 11. Box plots of heart rate changes after boxing training; bpm: beats per minute. ** p < 0.01
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There were no significant group x time interactions for aortic size (F(1,18) < 0.01, p =
0.969), interventricular septum thickness (F(1,18) = 0.09, p = 0.764), left ventricle end diastolic
dimension (F(1,18) = 0.27, p = 0.612), posterior wall thickness (F(1,18) = 2.17, p = 0.158),
ejection fraction (F(1,18) = 0.010, p = 0.762), left ventricle mass (F(1,18) = 0.91, p = 0.352), end
diastolic volume (F(1,18) = 0.73, p = 0.405), stroke volume (F(1,18) = 0.01, p = 0.907), and
lateral tissue doppler imaging (e’: F(1,18) = 0.31, p = 0.586; a’: F(1,18) = 0.37, p = 0.551)
However, there was a significant group effect for ejection fraction (F(1,18) = 4.65, p = 0.045)
(Table 8). A lower ejection fraction value was observed in the control group compared to the
boxing group at the post assessment (F(1,18) = 4.80, p = 0.042, η6 = 0.211). No differences were
observed in aortic size (F(1,18) < 0.01, p = 0.777), interventricular septum thickness (F(1,18) <
0.01, p = 0.985), left ventricle end diastolic dimension (F(1,18) = 0.30, p = 0.591), posterior wall
thickness (F(1,18) = 1.31, p = 0.268), ejection fraction (F(1,18) = 3.60, p = 0.074), left ventricle
mass (F(1,18) = 1.31, p = 0.268), end diastolic volume (F(1,18) = 0.19, p = 0.671), stroke
volume (F(1,18) = 1.34, p = 0.262), and lateral tissue doppler imaging (e’: F(1,21) < 0.01, p =
0.949; a’: F(1,21) = 0.37, p = 0.553) between groups at baseline.
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Table 8. Echocardiographic characteristics before and after 6 weeks intervention.
Boxing Training
Before
After
Δ

Before

Control
After

Δ

Interaction
p

Group
p

Time
p

Ao SV (mm)

29.5
(1.7)

29.3
(1.6)

-0.2

29.2
(2.4)

29.3
(1.6)

0.1

0.969

0.767

0.42

IVSd (mm)

9.2
(1.5)

9.4
(1.5)

0.2

9.2
(0.7)

9.3
(0.7)

0.1

0.764

0.977

0.047

LVEDD (mm)

42.6
(6.1)

42.3
(5.5)

-0.3

41.1
(5.6)

40.4
(5.8)

-0.7

0.612

0.513

0.288

PWd (mm)

9.5
(1.5)

9.0
(1.6)

-0.5

8.8
(1.3)

8.7
(1.3)

-0.1

0.158

0.414

0.054

LV EF (%)

61.8
(7.0)

61.6
(6.9)

-0.2

56.0
(6.6)

55.2
(6.1)

-0.8

0.762

0.045

0.614

LV Mass (g)

133.8
(41.4)

127.6
(46.2)

-6.2

116.7
(32.2)

114.6
(31.2)

-2.1

0.352

0.387

0.069

LV EDV (ml)

108.5
(26.0)

112.9
(33.3)

4.4

103.5
(25.4)

101.1
(24.6)

-2.4

0.405

0.480

0.802

SV (ml)

57.6
(12.0)

58.6
(18.7)

1.0

49.3
(19.1)

50.7
(18.4)

1.4

0.907

0.298

0.537

Lat e’ (cm/s)

13.8
(3.2)

14.9
(3.5)

1.1

13.9
(3.6)

14.5
(3.4)

0.6

0.586

0.920

0.076

Lat a’ (cm/s)

6.7
(1.4)

6.4
(1.4)

-0.3

7.2
(2.2)

7.3
(2.0)

0.1

0.551

0.342

0.765

Data expressed as mean (SD). Ao SV: aortic diameter at sinus of Valsalva; IVSd: end-diastolic interventricular
septum thickness; LVEDd: left ventricular end diastolic internal diameter; PWd, left ventricular end-diastolic
posterior wall thickness; LV EF: left ventricle ejection fraction; EDV: end-diastolic volume; SV: stroke volume.

4.1.7. Body Composition
Significant group x time interactions were observed for weight (F(1,21) = 4.38, p =
0.049) and BMI (F(1,21) = 4.86, p = 0.039). There were medium weight (F(1,18) = 5.53, p =
0.029, η6 = 0.209) and BMI (F(1,18) = 5.12, p = 0.034, η6 = 0.196) gains in the control group.
There were no significant group x time interactions for %BF (F(1,21) = 0.04, p = 0.846), fat
mass (F(1,21) = 2.32, p = 0.142), lean mass (F(1,21) = 0.27, p = 0.611), free fat mass (F(1,21) =
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0.26, p = 0.614), bone mineral content (F(1,21) = 0.02, p = 0.899), and bone mineral density
(F(1,21) = 0.01, p = 0.934) (Table 9). No differences were observed in weight (F(1,21) = 0.61, p
= 0.442), BMI (F(1,21) = 0.57, p = 0.459), %BF (F(1,21) = 0.32, p = 0.575), fat mass (F(1,21) =
0.54, p = 0.469), lean mass (F(1,21) = 0.17, p = 0.685), free fat mass (F(1,21) = 0.17, p = 0.682),
bone mineral content (F(1,21) = 0.25, p = 0.623), and bone mineral density (F(1,21) = 0.48, p =
0.496) between groups at baseline.

Table 9. Anthropometric and body composition changes following 6 weeks of intervention.
Boxing Training
Before
After
Δ

Before

Control
After

Δ

Interaction
p

Group
p

Time
p

Weight (kg)

89.3
(25.2)

89.0
(26.0)

-0.3

96.3
(16.4)

97.3
(17.0)

1.0

0.049

0.409

0.206

BMI

32.3
(7.8)

32.1
(8.1)

-0.2

34.5
(6.0)

34.9
(6.2)

0.4

0.039

0.417

0.300

Body Fat %

37.9
(12.3)

38.1
(12.1)

0.2

40.5
(6.4)

40.9
(9.0)

0.4

0.846

0.564

0.149

Fat Mass
(kg)

33.4
(16.6)

33.4
(16.4)

0

38.0
(12.9)

38.7
(13.0)

0.7

0.142

0.438

0.093

Lean Mass
(kg)

52.5
(13.6)

52.3
(14.1)

-0.2

54.5
(9.6)

54.7
(9.4)

0.2

0.611

0.664

0.94

Free Fat Mass
(kg)

55.4
(14.1)

55.2
(14.7)

-0.2

57.5
(10.0)

57.7
(9.7)

0.2

0.614

0.661

0.936

Bone Mineral
Content (kg)

2.9
(0.6)

2.9
(0.6)

0

3.0
(0.5)

3.0
(0.5)

0

0.899

0.62

0.886

Bone Mineral
Density
(gr/cm2)

1.3
(0.1)

1.3
(0.2)

0

1.3
(0.1)

1.3
(0.1)

0

0.934

0.514

0.240

Data expressed as mean (SD).
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4.1.8. Lipid Profile
There were no significant group x time interactions for HDL-C (F(1,20) = 0.82, p =
0.376), LDL-C (F(1,20) = 0.02, p = 0.894), and total cholesterol (F(1,20) = 0.93, p = 0.347)
(Table 10). No differences were observed in HDL-C (F(1,20) = 0.32, p = 0.576), LDL-C
(F(1,20) = 0.31, p = 0.581), and total cholesterol (F(1,20) = 1.79, p = 0.196) between groups at
baseline.

Table 10. Lipid profile changes following 6 weeks of intervention.
Boxing Training
Before
After
Δ
42.6
41.2
-1.4
(11.4)
(13.0)

HDL-C
(mg/dl)

Before
45.3
(10.5)

Control
After
47.2
(9.0)

Δ
1.9

Interaction
p
0.376

Group
p
0.332

Time
p
0.905

LDL-C
(mg/dl)

56.7
(1.8)

57.5
(2.1)

0.8

56.2
(2.6)

56.8
(2.1)

0.6

0.894

0.494

0.074

Total Cholesterol
(mg/dl)

132.0
(4.6)

132.0
(5.7)

0

134.7
(4.8)

131.9
(3.9)

-2.8

0.347

0.383

0.337

Data expressed as mean (SD). HDL-C: high density lipoprotein; LDL-C: low density lipoprotein.

4.1.9. Quality of Life
Significant group x time interactions were observed for role limitations due physical
health problems (F(1,21) = 10.02, p = 0.003), role limitations due emotional problems (F(1,21) =
4.19, p = 0.05), and general health (F(1,21) = 8.30, p = 0.009). A large increase in general health
(F(1,21) = 13.54, p = 0.001 η6 = 0.392) was observed in the boxing group after the intervention.
Large reductions in role limitations due physical health problems (F(1,21) = 8.71, p = 0.008, η6
= 0.293) and role limitations due emotional problems (F(1,21) = 11.19, p = 0.003, η6 = 0.348)
were observed in the control group at the end of the intervention. There were a significant group
effects for vitality (F(1,21) = 5.74, p = 0.026) and mental health (F(1,21) = 7.95, p = 0.01)
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(Table 11). Lower scores in vitality (F(1,21) = 7.80, p = 0.011, η6 = 0.271) and mental health
(F(1,21) = 9.11, p = 0.007, η6 = 0.303) were observed in the boxing group compared to the
control group at the post assessments. No differences were observed in physical functioning
(F(1,21) = 0.90, p = 0.767), role limitations due emotional problems (F(1,21) = 0.11, p = 0.749),
vitality (F(1,21) = 2.57, p = 0.124), social functioning (F(1,21) = 0.75, p = 0.397), bodily pain
(F(1,21) = 0.28, p = 0.606), and general health (F(1,21) = 0.67, p = 0.434) between groups at
baseline. Meanwhile, there were differences in role limitations due physical health problems
(F(1,21) = 4.60, p = 0.044) and mental health (F(1,21) = 4.81, p = 0.040) between groups at
baseline.

Table 11. Quality of life changes following 6 weeks of intervention.
Boxing Training
Before
After
Δ

Before

Control
After

-3.6

Interaction
p
0.082

Group
p
0.768

Time
p
0.533

Physical Functioning
(%)

81.7
(25.2)

89.2
(24.6)

7.5

84.6
(20.1)

81.0
(20.4)

Role limitation
Physical (%)

85.4
(22.5)

97.9
(7.2)

12.5

100
(0)

77.3
(30.5)

-22.7

0.003

0.618

0.348

Role limitation
Emotional (%)

77.8
(41.0)

72.2
(44.5)

-5.6

72.7
(32.7)

36.4
(27.7)

-36.3

0.050

0.149

0.011

Vitality (%)

60.0
(17.7)

66.7
(22.1)

6.7

49.6
(12.9)

46.4
(9.8)

-3.2

0.067

0.026

0.502

Mental Health (%)

73.7
(19.4)

76.3
(21.9)

2.6

58.2
(13.7)

54.2
(10.9)

-4.0

0.232

0.010

0.808

Social Functioning
(%)

78.1
(22.1)

86.5
(18.0)

8.4

70.5
(20.4)

68.2
(18.0)

-2.3

0.272

0.068

0.527

Bodily Pain
(%)

89.4
(18.5)

92.7
(8.7)

3.3

85.5
(17.2)

77.5
(17.7)

-8

0.098

0.115

0.486

General Health (%)

53.8
(24.7)

63.3
(22.5)

9.5

49.1
(18.7)

52.7
(16.5)

3.6

0.009

0.362

0.039

Data expressed as mean (SD).

81

Δ

4.1.10. Vascular Adaptations
There was a significant group x time interaction for brachial FMD (F(1,21) = 22.46, p <
0.001). No differences were observed in brachial artery diameter (F(1,21) = 0.33, p = 0.573),
resting brachial ESS (F(1,21) < 0.01, p = 0.967), and brachial FMD (F(1,21) = 0.03, p = 0.858)
between groups at baseline. Six weeks of boxing training largely increased brachial FMD
(F(1,21) = 23.58, p < 0.001, η6 = 0.529) in individuals with elevated blood pressure or stage 1
hypertension. There were no significant group x time interactions for brachial artery diameter
(F(1,21) = 3.05, p = 0.095) and resting brachial ESS (F(1,21) = 0.75, p = 0.398) (Table 12 and
Figure 12).
Significant group x time interactions were observed for popliteal artery diameter (F(1,14)
= 7.74, p = 0.015) and popliteal FMD (F(1,14) = 18.39, p = 0.001). No differences were
observed in popliteal artery diameter (F(1,14) = 3.90, p = 0.068), resting popliteal ESS (F(1,14)
= 1.35, p = 0.264), and popliteal FMD (F(1,14) = 0.03, p = 0.858) between groups at baseline.
Six weeks of boxing training induced a large increase in popliteal artery FMD (F(1,14) = 20.19,
p = 0.001, η6 = 0.591) and popliteal artery diameter (F(1,14) = 7.53, p = 0.016, η6 = 0.350).
There was no group x time interaction for resting popliteal ESS (F(1,14) = 0.92, p = 0.354)
(Table 12 and Figure 13).
There was a significant group x time interaction for carotid artery diameter (F(1,21) =
13.44, p = 0.001). No differences were observed in carotid artery diameter (F(1,21) = 3.43, p =
0.078) and resting carotid ESS (F(1,21) = 0.10, p = 0.750) between groups at baseline. A large
increase in carotid artery diameter (F(1,21) = 11.68, p = 0.003, η6 = 0.357) was observed in the
boxing group at the end of the intervention. There was no group x time interaction for resting
carotid ESS (F(1,21) = 1.55, p = 0.228) (Table 12 and Figure 14).
82

Table 12. Vascular changes following 6 weeks of intervention.
Boxing Training
Before After
Δ

Before

Control
After

Δ

Interaction
p

Group
p

Time
p

Brachial Diameter
(mm)

3.7
(0.6)

3.8
(0.7)

0.1

3.9
(0.6)

3.8
(0.7)

-0.1

0.095

0.881

0.895

Resting Brachial ESS
(dynes/cm2)

31.7
(6.2)

30.0
(6.9)

-1.7

31.6
(6.4)

28.1
(5.1)

-3.5

0.398

0.674

0.022

Brachial FMD
(%)

8.5
(4.8)

11.5
(5.4)

3.0

8.2
(3.4)

7.0
(3.6)

-1.2

<0.001

0.191

0.061

Popliteal Diameter
(mm)

5.6
(1.1)

5.8
(1.1)

0.2

6.6
(1.0)

6.5
(0.9)

-0.1

0.015

0.108

0.411

Resting Popliteal ESS
(dynes/cm2)

19.3
(3.0)

20.5
(3.0)

1.2

22.2
(6.6)

21.6
(4.6)

-0.6

0.354

0.336

0.760

Popliteal FMD
(%)

8.4
(2.6)

11.0
(3.3)

2.6

8.2
(5.0)

7.0
(4.2)

-1.2

0.001

0.265

0.12

Carotid Diameter
(mm)

6.7
(0.6)

7.0
(0.6)

0.3

7.2
(0.5)

7.0
(0.6)

-0.2

0.001

0.348

0.301

Resting Carotid ESS
(dynes/cm2)

32.4
(5.3)

34.4
(5.9)

2.0

33.3
(7.5)

32.6
(6.6)

-0.7

0.228

0.836

0.572

VOP Forearm Basal
(ml/min/100 ml tissue)

2.6
(0.8)

3.3
(1.0)

0.7

3.3
(0.9)

3.2
(1.1)

-0.1

0.003

0.469

0.019

VOP Forearm Peak
(ml/min/100 ml tissue)

17.1
(4.5)

20.9
(5.7)

3.8

14.9
(3.9)

14.8
(3.9)

-0.1

<0.001

0.037

<0.001

VOP Calf Basal
(ml/min/100 ml tissue)

2.7
(0.5)

3.0
(0.5)

0.3

3.2
(0.6)

3.2
(0.6)

0

0.134

0.143

0.126

VOP Calf Peak
(ml/min/100 ml tissue)

17.6
(4.3)

22.1
(6.2)

4.5

17.4
(6.9)

17.4
(6.2)

0

0.005

0.305

0.005

Data expressed as mean (SD). ESS: endothelial shear stress; VOP: venous occlusion plethysmography.
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Figure 12. Box plots of brachial artery changes after boxing training. a) Flow-Mediated Dilation (FMD);
b) Resting Endothelial Shear Stress (ESS); c) Brachial Artery Diameter. ** p < 0.01, *p < 0.05
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Figure 13. Box plots of popliteal artery changes following boxing training. a) Flow-Mediated Dilation
(FMD); b) Resting Endothelial Shear Stress (ESS); c) Artery Diameter. ** p < 0.01, *p < 0.05

Figure 14. Box plots of common carotid artery changes following boxing training. a) Artery diameter;
b) Resting Endothelial Shear Stress (ESS). *p < 0.05
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There were significant group x time interactions for basal forearm blood flow (F(1,21) =
10.88, p = 0.003), peak forearm blood flow (F(1,21) = 20.17, p < 0.001), and peak calf blood
flow (F(1,21) = 9.71, p = 0.005). No differences were observed in basal forearm blood flow
(F(1,21) = 3.70, p = 0.068), peak forearm blood flow (F(1,21) = 1.53, p = 0.230), and peak calf
blood flow (F(1,21) = 0.01, p = 0.912), while differences were found in basal calf blood flow
(F(1,21) = 4.58, p = 0.044) between groups at baseline. Six weeks of boxing training led to a
large increase in basal forearm blood flow (F(1,21) = 17.79, p < 0.001, η6 = 0.459), peak
forearm blood flow (F(1,21) = 39.94, p < 0.001, η6 = 0.655), and peak calf blood flow (F(1,21) =
20.58, p < 0.001, η6 = 0.495) (Figure 15 and Table 12).

Figure 15. Box plots of venous occlusion plethysmography (VOP) of resistance vessels changes following boxing
training. a) Forearm basal flow; b) Forearm peak flow; c) Calf basal flow; d) Calf peak flow. *** p < 0.001.
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4.1.11. Nitric Oxide Bioavailability
A significant group x time interaction was observed for NOx (F(1,20) = 10.08, p =
0.005). NOx was similar between groups at baseline (F(1,20) = 0.67, p = 0.424). A large increase
in NOx (F(1,20) = 8.37, p = 0.009, η6 = 0.295) was found in the boxing group at the end of the
intervention (Figure 16 and Table 13).

Table 13. Blood biomarkers changes following 6 weeks of intervention.
Boxing Training
Before
After
Δ

Before

Control
After

Δ

Interaction
p

Group
p

Time
p

NOx (μmol/L)

53.9
(19.6)

68.4
(23.3)

14.5

60.7
(19.9)

52.7
(26.5)

-8

0.005

0.627

0.370

CRP (mg/L)

9.1
(7.3)

5.9
(5.1)

-3.2

6.3
(4.4)

6.6
(4.6)

0.3

0.010

0.643

0.028

IL-6 (pg/ml)

19.1
(18.3)

19.0
(15.3)

-0.1

15.3
(13.8)

14.7
(14.9)

-0.6

0.851

0.546

0.810

TNFα (pg/ml)

126.9
(185.7)

134.2
(183.6)

7.3

91.4
(138.5)

81.1
(139.7)

-10.3

0.203

0.605

0.244

8-isoprostane
(pg/ml)

465.1
(108.0)

487.3
(139.7)

22.2

440.2
(142.2)

535.7
(159.2)

95.5

0.364

0.792

0.152

SOD (mU/ml)

44.5
(6.2)

44.7
(6.4)

0.2

43.7
(6.5)

43.5
(6.9)

-0.2

0.731

0.710

1.000

TAC (mM/ml)

5.6
6.8
1.2
5.2
4.8
-0.4
0.151
0.242 0.408
(2.5)
(3.5)
(2.7)
(2.0)
Data expressed as mean (SD). NOx: nitric oxide; CRP: c-reactive protein; IL: interleukin; SOD: superoxide dismutase;
TAC: total antioxidant capacity.
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Figure 16. Box plots of Nitric Oxide changes after the intervention. * p < 0.05.

4.1.12. Inflammation
A significant group x time interaction was observed for CRP (F(1,20) = 8.03, p = 0.01).
No differences were observed in CRP (F(1,20) = 0.11, p = 0.745), IL-6 (F(1,20) = 0.30, p =
0.593), and TNF-α (F(1,18) = 0.23, p = 0.641) between groups at baseline. Six weeks of boxing
training largely reduced CRP (F(1,20) = 13.53, p = 0.001, η6 = 0.404) (Figure 17 and Table 13).
A significant group x time interaction was also found for CRP (F(1,14) = 6.37, p = 0.024) when
CRP values >10 mg/L in the pre assessment were excluded (Appendix B). There were no
significant group x time interactions for IL-6 (F(1,20) = 0.36, p = 0.851) and TNF- α (F(1,20) =
1.74, p = 0.203) (Table 13).
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✱✱

Figure 17. Box plots of C-Reactive Protein changes after the intervention. ** p < 0.01.

4.1.13. Oxidative Stress
There were no group x time interactions for 8-isoprostane (F(1,20) = 0.86, p = 0.364),
SOD (F(1,20) = 0.12, p = 0.731), and TAC (F(1,20) = 2.23, p = 0.151) (Table 13). No
differences were observed in 8-isoprostane (F(1,20) = 0.21, p = 0.649), SOD (F(1,20) = 0.07, p =
0.791), and TAC (F(1,20) = 0.16, p = 0.693) between groups at baseline.
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4.2. Experiment 2: Cross Sectional Study
A total of 10 participants (7 males and 3 females) with elevated blood pressure or stage 1
hypertension were recruited for the present study. Data was normally distributed and was
presented as mean (standard deviation). Demographic characteristics are display in Table 14.

Table 14. Demographic characteristics of the participants.

N = 10
Age (y)

24.7 (4.2)

Height (m)

1.7 (0.1)

Weight (kg)

72.5 (13.0)

Hematocrit (%)

48.7 (2.5)

SBP (mmHg)

127.4 (4.6)

DBP (mmHg)

79.1 (5.0)

Data expressed as mean (SD). SBP: systolic blood pressure; DBP: diastolic blood pressure.

Heart rate, VO2, lactate, and RPE were significantly increased during both exercise
conditions (all p < 0.001) in comparison to baseline. Also, all these exercise variables were
higher at 95%VO2max in comparison to 60%VO2max (all p < 0.001) (Table 15).

Table 15. Exercise variables during boxing training
N = 10

Baseline

60%VO2max

95%VO2max

Heart Rate (bpm)

68.8 (11.7)

129.0 (12.5)*

164.7 (18.3)*&

VO2 (ml/kg/min)

3.5 (0.7)

12.9 (2.8)*

21.3 (5.0)*&

Lactate (mmol/L)

0.8 (0.4)

2.4 (0.6)*

5.2 (1.3)*&

0

10.7 (2.5)*

15.9 (2.8)*&

ESS Anterograde (dynes/cm2)

32.6 (8.9)

47.2 (11.3)*

77.4 (17.2)*&

ESS Retrograde (dynes/cm2)

0

6.9 (4.5)*

19.5 (10.2)*&

RPE (6-20)

Data expressed as mean (SD). VO2: oxygen uptake; RPE: rate of perceive exertion; ESS: endothelial shear stress.
* = p < 0.05 vs Baseline; *& = p < 0.05 vs 60%VO2max.
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There was a large significant increase in anterograde ESS during boxing training at both
intensities in comparison to resting conditions (p < 0.05, d = 1.44 – 3.27). Additionally, there
was a large increase in anterograde ESS at 95%VO2max in comparison to ESS at 60%VO2max
(p < 0.001, d = 2.08) (Figure 18).
Retrograde ESS followed the same trend as anterograde ESS. There was a large increase
in retrograde ESS at both exercise conditions in comparison to baseline (p < 0.05, d = 2.17 –
4.00), while a large increase in retrograde ESS was observed at 95%VO2max in comparison to
ESS at 60%VO2max (p < 0.001, d = 2.16) (Figure 18).

Figure 18. Carotid artery endothelial shear stress (ESS) during boxing training at 60%VO2max and
95%VO2max. *** p < 0.001.
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Anterograde blood flow patterns were turbulent at baseline and during both exercise
conditions. Meanwhile, retrograde blood flow patterns were laminar at 60%VO2max and there
was a tendency to become turbulent at 95%VO2max (Figure 19).

Figure 19. Blood flow patterns in the common carotid artery during boxing training at 60%VO2max and
95%VO2max.
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CHAPTER 5: DISCUSSION
The present study is the first randomized controlled trial to evaluate the effects of boxing
training on brachial blood pressure, central blood pressure, arterial stiffness, exercise capacity,
cardiac adaptations, body composition, lipid profile, quality of life, vascular adaptations, nitric
oxide bioavailability, inflammation, and oxidative stress in individuals with elevated blood
pressure or stage 1 hypertension. The main findings we identified were that 6 weeks of boxing
training with a polarized intensity regime in individuals with elevated blood pressure or stage 1
hypertension improves: (1) clinical outcomes, such as peripheral and central blood pressure,
resting heart rate, VO2max, ventilatory and lactate thresholds, and quality of life, and (2)
vascular outcomes, specifically, improving conduit artery endothelial function, resistance vessels
structure and endothelial function, and carotid artery structure, all changes linked to an increase
in NO bioavailability and a decrease in inflammation. Additionally, the present study is the first
one to assess blood flow changes in the carotid artery during a novel exercise modality and to
determine that ESS and blood flow patterns during boxing training, may be involved with
structural or functional adaptations in the vasculature of individuals with elevated blood pressure
or stage 1 hypertension.

5.1. Boxing Training
To the best of our knowledge, this is the first study to evaluate the effects of boxing
training on cardiovascular health in individuals with elevated blood pressure or stage 1
hypertension. The boxing training regimen consisted of ~43 minutes workouts (3-minute warm
up and 10 rounds of 3-minute punching interspersed with 1-minute passive resting) on 3 nonconsecutive days per week for 6 weeks. The intensity of each session had a polarized design,
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where 30% and 70% of the time corresponded to high- and low-intensity exercise, respectively.
The high compliance to the exercise sessions observed in the present study (98.1%) suggest that
this approach is suitable for physically inactive individuals and for beginners in boxing training.
In addition, the compliance to boxing training from the present study was superior to the one
described by the Cheema et al. [52] study (~79%). These differences may be explained by the
characteristics of the present boxing training program, which may be more appealing to
physically inactive individuals compared to the Cheema et al. program specifically due to the
intensity (Polarized versus HIIT) and duration (6 weeks versus 12 weeks).
Polarized training has been shown to be very successful for improving performance in
athletes [310-314]; however, there is limited research on the effectiveness of polarized training
on clinical outcomes in the CVD population. In an elegant study, Zapata-Laman et al. [146]
compared the effects of 12-week polarized training, moderate-intensity training, or HIIT on
cardiometabolic risk in young overweight and obese women. They found that polarized training
had superior effects on exercise capacity, glycemic control, and substrate oxidation in
comparison to the other training modalities. These findings suggest that polarized training is an
appropriate approach to control cardiovascular risk factors in CVD population.
In the present study, no cardiovascular adverse events were detected. However, 25% of
the participants experienced self-limiting shoulder pain when punching during their first week of
training, which subsided during the second week and no further pain was reported. Thus, boxing
training can still be considered safe in individuals with elevated blood pressure or stage 1
hypertension. Caution should be taken in using boxing training in individuals who have a preexisting shoulder injury (e.g. rotator cuff tendinopathy).
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5.2. Clinical Outcomes
5.2.1. Peripheral Blood Pressure
The present study demonstrated that 6 weeks of boxing training induced a large reduction
in brachial SBP (~16 mmHg) and DBP (~10 mmHg) in individuals with elevated blood pressure
or stage 1 hypertension (Table 5 and Figure 7). Similarly, Cheema et al. [52] reported 14 and 7
mmHg reductions in SBP and DBP, respectively, after 16 weeks of boxing training in adults with
abdominal obesity. The findings of the present study are also in agreement with previous metaanalyses studying the effects of exercise in blood pressure. For example, Cornelissen et al. [18]
reported an overall reduction in SBP/DBP of 3.5/2.5, 1.8/3.2, and 10.9/6.2 mmHg in endurance,
resistance, and isometric training, respectively, in healthy or individuals with high blood
pressure. In addition, de Sousa et al. [28] reported 8.3 and 4.1 mmHg reductions in SBP and
DBP, respectively, after resistance training in individuals with high blood pressure. Furthermore,
Inder et al. [29] reported 5.2 and 3.9 mmHg reductions in SBP and DBP, respectively, after
isometric exercise training in healthy or individuals with high blood pressure. Moreover,
Williamson et al. [315] reported 4.4 and 4.2 mmHg reductions in SBP and DBP, respectively,
after a physical activity intervention in young adults with elevated blood pressure, stage 1
hypertenson, or stage 2 hypertension. The SBP and DBP reductions described in those metaanalyses were lower than the reductions from the present study and the Cheema et al. study. The
differences may rely on the intrinsic nature of boxing training, which is a whole-body physical
activity but with an upper-body emphasis, that could induce more prominent local changes in the
brachial artery (e.g. higher ESS). Also, heterogeneity in the studies that were included in those
meta-analyses (e.g. exercise prescription, sample size, adherence) may affect the net
observations. Blood pressure reductions following boxing training may be explained, in part, to
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an improvement in ESS, NO bioavailability, and endothelial function and a reduction in vascular
inflammation and peripheral vascular resistance (Tables 12 and 13).
Lewington et al. [316] reported that a 10 mmHg reduction in SBP results in a 30%
decreased risk in coronary artery disease mortality and a 40% decreased risk in stroke mortality.
In the same study, Lewington et al. reported that even smaller reductions (~2 mmHg) in SBP
results in a 7% and 10% decreased risk in coronary artery disease and stroke mortality,
respectively. Additionally, Verdecchia et al. [317] reported that a 2 mmHg reduction in DBP
results in a 12% decrease risk of myocardial infarction, stroke, and cardiovascular mortality.
Based on these previous findings, the results of the present study are clinically meaningful
findings.

5.2.2. Central Blood Pressure
Central hemodynamics represent the pressure in the ascending aorta and downstream
(e.g. end-organs). An elevation of the central blood pressure has an adverse effect on the
vasculature and on end-organs, especially in the high blood pressure population [318].
Additionally, central blood pressure is recognized as a more powerful maker of end-organ
damage and cardiovascular mortality compared to brachial blood pressure [99,319].
In the present study, 6 weeks of boxing training largely reduced cSBP (~8 mmHg) in
individuals with elevated blood pressure or stage 1 hypertension (Table 6 and Figure 8). Similar
to the findings from the present study, Beck et al. [320] reported a reduction in cSBP after 8
weeks of endurance (~11 mmHg) or resistance training (~10 mmHg) in young individuals with
elevated blood pressure or stage 1 hypertension. This finding may be explained by an exerciseinduced vasodilatory effect on resistance vessels in individuals with high blood pressure that
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reduced the magnitude of reflected pressure waves. Additionally, in the present study, no
statistical reductions were observed in AIx or AIx@75 after 6 weeks of boxing training in
individuals with elevated blood pressure or stage 1 hypertension (Table 6). Previous studies have
reported equivocal findings regarding the effects of exercise on AIx. Cheema et al. [52] reported
a reduction in AIx after 16 weeks of boxing training in adults with abdominal obesity. Donley et
al. [321] reported a reduction in cSBP and AIx@75 after 8 weeks of endurance training in adults
with metabolic syndrome. Krustrup et al. [322] reported reductions in AIx after 12 and 24 weeks
of soccer training in males with high blood pressure. Nualnim et al. [243] reported a no
significant reduction in AIx after 12 weeks of swimming training in elderly individuals with high
blood pressure. Seals et al. [323] reported no changes in AIx after 12 weeks of walking training
in elderly women with high blood pressure women. Westhoff et al. [323] reported no changes in
AIx and AIx@75 after of upper-body endurance training in elderly individuals with high blood
pressure. Lastly, Heffernan et al. [324] reported no changes in AIx following 12 weeks of
resistance training in elderly individuals with high blood pressure. These incongruent results may
be explained by the heterogenicity in exercise programs and sample characteristics (e.g. age, sex,
morbidity) among studies.
Based on the findings of Vlachopoulos et al. [325], who reported that a 10 mmHg
reduction in cSBP translates into a 8.8% decrease in the risk for future cardiovascular events, we
propose that the findings of the present study are clinically relevant because a mean reduction of
~8 mmHg was observed after 6 weeks of boxing training in individuals with elevated blood
pressure or stage 1 hypertension.
Finally, in the present study, a no significant reduction in LVEW (~37%) was observed
after 6 weeks of boxing in individuals with elevated blood pressure or stage 1 hypertension
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(Table 6). LVEW is a relatively new biomarker that describes the additional energy required by
the myocardium to overcome the augmented pressure generated by the reflected pressure wave.
Thus, reductions in LVEW may prevent the progression to pathological ventricular hypertrophy
secondary to high blood pressure [326]. There are only few studies that have explored the effects
of exercise on LVEW. For example, Beck et al. [320] reported a reduction in LVEw after 8 weeks
of endurance (~76%) or resistance training (~82%) in young individuals with elevated blood
pressure or stage 1 hypertension. Based on these and the current study results, significant
reductions in LVEw might be seeing after longer training periods.

5.2.3. Arterial Stiffness
Large-artery stiffness is an independent risk factor for cardiovascular mortality and it is
usually associated with high blood pressure [327]. In fact, it has been proposed that arterial
stiffness is a mechanism behind the development or progression of high blood pressure
[328,329]. PWVcf is the gold standard to assess arterial stiffness and its reduction is associated
to better cardiovascular outcomes [330,331].
In the present study, no changes in PWVcf were observed after 6 weeks of boxing
training in individuals with elevated blood pressure and stage 1 hypertension (Figure 9). These
findings are in agreement with those of previous studies. Beck et al. [320] reported no changes in
PWVcf after 8 weeks of endurance or resistance training in individuals with elevated blood
pressure or stage 1 hypertension. Ferrier et al. [332] reported no PWVcf change following 8
weeks of cycling training in individuals with high blood pressure. Seals et al. [323] reported no
effects on PWVcf after 12 weeks of endurance training in postmenopausal women with high
blood. Stewart et al. [333] reported no significant changes in PWVcf after 24 weeks of
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endurance and resistance training in elderly individuals with high blood pressure in comparison
to a control group. Lastly, Guimaraes et al. [201] reported a small reduction and no changes in
PWVcf after 16 weeks of interval or continuous endurance training in individuals with high
blood pressure. In contrast, Madden et al. [334] reported ~3 m/s and ~1 m/s reductions in PWVcf
after 12 and 24 weeks of endurance training in individuals with high blood pressure with other
cardiovascular comorbidities. Interestingly, Collier et al. [213] reported that 4 weeks of
resistance increased PWVcf and 4 weeks of endurance training reduced PWVcf in individuals
with high blood pressure. In a recent study, Bhuva et al. [335] reported a reduction in PWV
across the length of the whole aorta measured by cardiovascular magnetic resonance after 24
weeks of endurance training in healthy sedentary individuals. Overall, exercise training programs
shorter than 6 weeks are less likely to induce structural adaptations in elastic arteries in
individuals with high blood pressure.

5.2.4. Cardiorespiratory Fitness
Exercise training has been extensively reported to increase cardiorespiratory fitness
[31,336]. In the present study, 6 weeks of boxing training improved upper-body power output
(~16%), VO2max (~32%), and ventilatory (~29%) and lactate (~23%) thresholds in individuals
with elevated blood pressure or stage 1 hypertension (Table 7 and Figure 10). The present
findings confirm previously reported data regarding improvements in cardiorespiratory fitness
through exercise in individuals with CVD. Cheema et al. [52] reported a 16.9% increase in
VO2max after 16 weeks of boxing training in adults with abdominal obesity. Azadpour et al.
[337] reported a 22.7% rise in VO2max after 10 weeks of endurance training in individuals with
elevated blood pressure or stage 1 hypertension. Miyatake et al. [338] reported an increase in
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exercise performance at the ventilatory threshold and a 12.4% rise in VO2max after 48 weeks of
low-intensity endurance exercise in individuals with high blood pressure and obesity. Moreover,
Dimeo et al. [339] reported a right shift in the lactate threshold curve and a 6.6% increase in
VO2max after 8- to 12- weeks of endurance training in individuals with high blood pressure.
Improvements in the cardiorespiratory fitness are explained by changes at both central (e.g.
maximal cardiac output) and peripheral (e.g. maximal arterial-venous oxygen difference) levels.
Approximately two-thirds of the gains are explained by modifications at the central level such as
greater stroke volume during exercise due to enhance left ventricular filling and contractility.
The remaining third is explained by changes at the peripheral level such as greater
capillarization, muscle fibers adaptations, reduced vascular peripheral resistance, improvement in
enzymatic activity, and microvascular blood flow distribution [340,341].

5.2.5. Cardiac Adaptations
The present study demonstrated that 6 weeks of boxing training reduced resting heart
rate (~10 bpm) in young individuals with elevated blood pressure or stage 1 hypertension (Figure
11). This finding was consistent with those of previous studies. Collier et al. [213] reported a
reduction in resting heart rate (~5 bpm) after 4 weeks of endurance training in individuals with
high blood pressure. Laterza et al. [200] reported a reduction in resting heart rate (~10 bpm) after
16 weeks of cycling training in never-treated hypertensive patients. Lamina et al. [189] reported
a reduction in heart rate (~10 bpm) after 8 weeks of cycling training in individuals with high
blood pressure.
In the present study, no changes in cardiac structure or diastolic function were observed
after 6 weeks of boxing training in young individuals with elevated blood pressure or stage 1
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hypertension (Table 8). Previous studies have reported equivocal findings regarding the effects
of exercise on cardiac morphology and function. Guirado et al. [236] reported no changes in
cardiac structure and diastolic function after 24 weeks of combined endurance and resistance
training in individuals with high blood pressure. Pitsavos et al. [191] reported a reduction in
resting heart rate, interventricular septum thickness, left ventricular posterior wall thickness, left
ventricular end diastolic internal diameter, and left ventricular mass after 16 weeks of cycling
training in high blood pressure adults. Turner et al. [229] reported a decrease in left ventricular
posterior wall thickness and left ventricle mass index after 7 weeks of endurance training in older
adults with high blood pressure. Hinderliter et al. [230] reported a reduction in interventricular
septum thickness and left ventricular posterior wall thickness after 24 weeks of endurance
training in overweight adults with high blood pressure. Rinder et al. [231] reported a reduction in
interventricular septum thickness, left ventricular posterior wall thickness, and left ventricular
mass after 24 weeks of endurance training in elderly individuals with high blood pressure.
Lastly, Boman et al. [232] reported a reduction in heart rate, interventricular septum thickness,
left ventricular posterior wall thickness, and left ventricular mass in a physically active
individuals with high blood pressure compared to sedentary individuals with high blood
pressure. Based on the findings of these previous studies, exercise may reverse pathological left
ventricular remodeling in middle-age and elderly adults with high blood pressure. Potential
mechanisms have been studied in animal models with high blood pressure, who have described
that exercise reduces apoptosis in cardiomyocytes, increases vagal tone, and improves coronary
circulation [228]. Additionally, in the present study, no clinically meaningful change was
observed for systolic function following 6 weeks of boxing training in individuals with elevated
blood pressure or stage 1 hypertension (Table 8). Although a significant lower ejection fraction
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was detected in the control group (~55.2%) in comparison to the boxing group (~61.6%) at the
end of the intervention, the difference in ejection fraction over time for both groups was less than
1%. Moreover, pre- and post- ejection fraction estimations in both groups were within normal
limits (52-74%) [342].

5.2.6. Body Composition
Conflicting findings have been described regarding the effectiveness of exercise training
to reduce weight and BMI and to have the ability to modify body composition independently
[343-345]. In the present study, no changes in weight, BMI, %BF, lean mass, fat mass, fat free
mass, bone mineral content, or bone mineral density were reported after 6 weeks of boxing
training in individuals with elevated blood pressure or stage 1 hypertension (Table 9). Weight
and BMI findings from the present study were in agreement with the findings from Beck et al.
[215] who reported no weight or BMI changes after 8 weeks of endurance or resistance training
in individuals with elevated blood pressure or stage 1 hypertension, and Schultz et al.[53] who
also reported no weight or BMI changes after 12 weeks of boxing training in obese adolescent
males. In contrast, Cheema et al. [52] reported reductions in weight and BMI by 4.1% and 4%,
respectively, after 16 weeks of boxing training in adults with abdominal obesity. Interestingly,
in the present study a weight gain of ~1 kg was observed at the end of the intervention in the
control group. About 70% of this weight gain corresponded to fat mass. Young adults tend to
increase their weights during college, which is closely associated to physical inactivity and poor
eating habits [346]. Boxing training may confer some degree of protection against weight gains
in young adults who attend college.
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There is limited evidence overall on the effects of exercise training on body composition
measured by DXA in high blood pressure population. For example, Tomeleri et al. [347]
reported an increase in lean mass and a reduction in %BF after 12 weeks of resistance training in
older women with high blood pressure. These findings were not consistent with those of the
present study, which could be explained due to differences in sample size, age, and exercise
program characteristics among studies, especially program length.
Finally, few studies have evaluated the effects of impact loading during exercise on bone
structure. For example, Bassey et al. [348] reported an increase in bone mineral density at the
trochanteric region of the femur after 24 weeks of intermittent lower-body high-impact exercise
training in premenopausal women. Kato et el. [349] reported an increase in bone mineral density
at the femoral neck after 24 weeks of low-repetition and high-impact training (e.g. 30 maximum
jumps per week) in female college students. Vainionpaa et al. [350] reported an increase in bone
mineral density at the femoral neck, trochanteric, and intertrochanteric regions after 48 weeks of
lower-body high-impact exercises in premenopausal females. Lastly, Lambert et al. [351]
reported an increase in areal bone mineral density at the radius after 40 weeks of high-impact
training that included upper-body punches in young healthy women. These findings reflect a sitespecific bone response to the mechanical load. The differences between these findings and those
from the present study may be explained in large part due to the different duration of the training
programs (e.g. 6 weeks versus minimum 24 weeks) and the use of different DXA settings during
image acquisition (i.e. whole body vs. specific region).
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5.2.7. Lipid Profile
Current clinical guidelines employ the lipid profile to estimate CVD risk [352,353]. Time
course reductions in LDL-C, total cholesterol, and triglycerides and an increase in HDL-C have
been shown to prevent CVD development [354]. In the present study, no changes in lipid profile
were described after 6 weeks of boxing training in individuals with elevated blood pressure or
stage 1 hypertension (Table 10). These findings were similar to Jarrete et al. [355] and Arca et al.
[356] who also reported no lipid profile modifications after 8-week endurance training and 12week aquatic training, respectively, in high blood pressure women. However, the findings of the
present study were not in agreement with other studies. Ammar et al. [357] reported that 12
weeks of endurance training in women with high blood pressure reduced LDL-C and increased
HDL-C. Zaros et al. [358] reported that 24 weeks of cycling training in women with high blood
pressure reduced total cholesterol. Lastly, Tsai et al. [173] reported reductions in total
cholesterol, LDL-C and triglycerides and an increase in HDL-C after 12 weeks of endurance
training in individuals with high blood pressure. These equivocal findings may be explained due
to the differences in exercise prescription among studies, or mainly, the duration of the exercise
program. In general, studies that have shown LDL-C reductions with exercise training relate
their effects to a concurrent weight loss rather than being produced by exercise itself.
Meanwhile, an increase in HDL-C is directly related to exercise training [359].

5.2.8. Quality of Life
Previous reports have established lower quality of life in individuals with high blood
pressure compared to normotensive individuals by using the SF-36 test [112-115]. Reversing
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high blood pressure has not shown to substantially improve quality of life. This suggests that
quality of life is more closely related to the presence of comorbidities [360].
In the present study, 6 weeks of boxing training significantly increased the perception of
general health (Table 11). Previous studies evaluating the effects of exercise on quality of life in
individuals with high blood pressure have reported equivocal results that could be explained by
differences in sample size or broad inter-individual variability. For example, Cheema et al. [52]
reported an improvement in physical functioning, vitality, and general health in adults with
abdominal obesity and high blood pressure after 12-week of boxing training. Additionally,
Molmen-Hansen et al. [192] reported an improvement in general health, social function, and
physical function in individuals with high blood pressure after 12 weeks of HIIT. Finally, Tsai et
al. [179] reported improvements in every domain except mental health in 52 Taiwanese
individuals with high blood pressure after 10 weeks of endurance training. The improvement in
general health due to exercise in the present study was the only domain that showed an
agreement with previous studies. Presumably, the improvement in cardiorespiratory fitness
positively affected the general health perception. In addition, our population was rather young
(~25 years old) what could explain a higher baseline quality of life already. Interestingly, in the
present study reductions in role limitations due physical health problems and role limitations due
emotional problems were observed in the control group. These findings could be related to
stress-related college factors such as poor sleep quality, academic performance, or economic
burden [361].
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5.3. Vascular Adaptations
Exercise-induced vascular adaptations have been extensively reported in healthy and
CVD individuals, including those suffering from high blood pressure [21,239]. These adaptations
are vessel-specific (e.g. elastic, conduit, and resistance arteries) [21] and are activity-dependent
(e.g. upper body versus lower body exercise) [240,241].
The present study demonstrated that 6 weeks of boxing training improves conduit artery
endothelial function in individuals with elevated blood pressure or stage 1 hypertension.
Specifically, brachial and popliteal mean FMD% increased by 3% and 2.6%, respectively (Table
12, Figure 12, and Figure 13). These findings were in agreement with the findings of Tinken et
al. [362] who reported that brachial and popliteal FMD% increased by 1.7% and 1.6% in
normotensive individuals after 6 weeks of endurance training. Similarly, Beck et al. [215]
showed an increase in brachial FMD% after 8 weeks of endurance training (~3.7%) and after 8
weeks of resistance training (~2.1%) in individuals with elevated blood pressure or stage 1
hypertension. In the same study, Beck et al. described a blunted endothelial response to
hyperemia in individuals with elevated blood pressure or stage 1 hypertension compared to
normotensive matched controls before the exercise intervention. The findings of the present
study were also in agreement with previous studies involving individuals with high blood
pressure. For example, Westhoff et al. [244] showed a 2.3% increase in brachial FMD% after 12week endurance training in elderly hypertensive individuals. Swift et al. [245] reported an
increase in brachial FMD% ranging from 1% to 1.5% after 24 weeks of endurance training in
postmenopausal women with hypertension. Nualnim et al. [243] reported a ~3.9% increase in
brachial FMD% after 12 weeks of swimming training in adults >50 years old with high blood
pressure. Finally, Molmen-Hansen et al. [192] reported a 4.2% increase in brachial FMD% after
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12 weeks of HIIT in individuals with high blood pressure. These FMD% improvements might be
explained by an increase in ESS during exercise, which in turn increases NO and decreases
inflammation [21,363-365]. Contrary to the present findings, no changes in brachial FMD%
were reported by Westhoff et al. [185] in individuals with high blood pressure after 12-weeks of
upper-body endurance exercise. Differences in endothelial responses in the present study and
those of Westhoff et al. may be explained by a lower ESS stimulus produced during armcranking in comparison to whole body exercise. For its part, Spence et al. [141] reported a
significant improvement in brachial FMD% after 24 weeks of resistance training (~1.9%) but not
after 24 weeks of endurance training in young healthy individuals, while no changes were
observed in femoral FMD% with either training modality.
In addition, the present study showed equivocal effects on the structure of conduit arteries
after 6 weeks of boxing training in individuals with elevated blood pressure or stage 1
hypertension. Specifically, there were significant increases in resting artery diameter, in the
common carotid artery (~0.3 mm) and in the popliteal artery (~0.2 mm) at the end of the
intervention but not in the brachial artery (Table 12, Figure 12, Figure 13, and Figure 14).
Similar findings have been described in previous studies. Dinenno et al. [366] reported an
increase in diameter in the femoral artery (~0.8 mm) but not in the brachial artery after ~14
weeks of walking or jogging training in normotensive sedentary individuals. Spence et al. [141]
reported an increase in diameter in the brachial artery (~0.3 mm) with resistance training but no
change with endurance training, an increase in diameter in the femoral artery diameter (~0.2
mm) with endurance training but not with resistance training, and no change in diameter in the
carotid artery following either exercise training modality in young healthy individuals. In
contrast, no exercise-induced structural adaptations have been described in previous studies that
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involved individuals with high blood pressure. For example, Nualnim et al. [243] reported no
changes in brachial and carotid artery diameters after 12 weeks of swimming training in adults
>50 years old with high blood pressure and Beck et al. [215] reported no change in brachial
artery diameter after 8 weeks of endurance or resistance training in individuals with elevated
blood pressure or stage 1 hypertension. Finally, the findings of the present study were not
entirely consistent with those of Tinken et al. [362] who reported no changes in brachial and
popliteal diameters in normotensive individuals throughout 8 weeks of endurance training.
However, Tinken et al. described a progressive increment in vasodilator capacity in both brachial
and popliteal arteries starting from week 2 in the same study, which can be interpreted as an
expression of artery remodeling. It has been suggested that adaptations of conduit arteries to
exercise training begin with an increase in endothelial function during the first weeks, followed
by artery remodeling (e.g. increase in diameter) to normalize resting ESS [21,362]. The results
from the present study support this last theory considering that resting ESS was not affected in
the carotid and popliteal artery after the boxing intervention despite the increase in diameters in
both arteries.
Further, resistance vessel adaptations were also observed in the present study through
venous occlusion plethysmography. The present boxing protocol increased baseline forearm
blood flow (~27%), peak forearm blood flow (~22%), and peak calf blood flow (~26%) (Table
12 and Figure 15). These changes reflected an augmented vascular ceiling capacity due to
capillary or arteriolar proliferation and an improvement in endothelial function. These findings
were in agreement with previous studies. Higashi et al. [167] reported an increase in peak
forearm blood flow (~23%) in individuals with high blood pressure were observed after 12weeks of brisk-walking, although baseline forearm blood flow remained unchanged after the
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intervention. Beck et al. [246] reported an increase in baseline forearm blood flow (~22%), peak
forearm flow (~31%), baseline calf blood flow (~33%), and peak calf blood flow (~44%) after 8
weeks of endurance or resistance training. Additionally, Beck et al. described that endothelial
function of resistance vessels was impaired in individuals with elevated blood pressure or stage 1
hypertension compared to normotensive controls. Based on previous studies, the findings from
the present study could be explained by a reduction in sympathetic tone, metabolic changes (e.g.
Angiotensin II and Endothelin-1 downregulation), and an increase in ESS [21].

5.3.1. Nitric oxide bioavailability
NO is a key molecule in the maintenance of vascular homeostasis and vascular health.
NO is produced by eNOS from its substrate, L-arginine, in endothelial cells. One of the most
important functions of NO is to act as a vasodilator by relaxing smooth muscle cells from the
tunica media of an artery. Also, NO can inhibit platelet adhesion and aggregation, decrease ROS
formation, and reduce inflammation. All these functions prevent endothelial dysfunction, which
is the first step in the development of CVD [367].
As NO half-life is relatively short, its direct quantification in blood is difficult.
Estimations of NO production is best accomplished by quantification of the final NO metabolites
nitrite/nitrate (NOx) [347]. The present study demonstrated that 6 weeks of boxing training in
individuals with elevated blood pressure or stage 1 hypertension elevates NOx in plasma by
nearly 27% (Table 13 and Figure 16). These results were in agreement with the findings of Beck
et al. [215] who reported an increase in NOx after 8 weeks of cycling (~31%) and resistance
training (~19%) in young individuals with elevated blood pressure or stage 1 hypertension.
Similarly, Tomeleri et al. [347] reported an increase in NOx after 12 weeks of resistance training
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(~35%) in older women with high blood pressure, while Izadi et al. [193] reported an increment
in NOx after 6 weeks of HIIT (~140%) in elderly individuals with high blood pressure.
Additionally, Hasegawa et al. [368] reported an increase in NOx after 6 weeks of HIIT (~31%)
and after 8 weeks of moderate-intensity cycling (~43%) in healthy young men. Moreover, Maeda
et al. [178] reported an increase in NOx (~60%) following 12 weeks of cycling at 80% of the
ventilatory threshold in healthy elderly women.
The potential mechanisms by which exercise might increases NO bioavailability in
plasma are not yet fully understood. However, it is believed that vascular homeostasis is closely
regulated by the mechanical interaction between blood flow and the endothelium through a
process known as ESS [369]. During exercise, there is a raise on pulsatility and ESS inside
arteries [21,370], which suggests that these hemodynamic changes may regulate the expression
of genes involved in NO production through a mechanotransduction pathway [21,62,371].

5.3.2. Inflammation
Low-grade chronic inflammation has been described as a hallmark in the
physiopathology of high blood pressure [83,372,373]. TNF-α, IL-6, and CRP are classic
inflammatory biomarkers employed to explore the inflammatory state of an individual
[86,90,374]. Several studies have shown a direct correlation between these biomarkers and high
blood pressure [86,89,375,376]. TNF-α is a primary inflammatory cytokine released by white
blood cells that stimulate visceral adipose tissue to secrete IL-6, a secondary inflammatory
cytokine, which in turn increases the production and excretion of CRP from the hepatocyte [376378]. Additionally, CRP can be secreted by other cell types including endothelial cells [379],
where it has shown to have deleterious autocrine and paracrine effects on them (e.g.
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overexpression of adhesion molecules) [380-382]. In the present study, CRP but neither TNF-α
or IL-6 decreases after 6 weeks of boxing training (Table 13 and Figure 17). These findings can
be explained due the fact that a short period of exercise training (e.g. 6 weeks) by itself does not
significantly affect body fat mass and specifically the amount of adipose tissue, consequently,
there may be no major modification in the adipocyte signaling pathway to alter TNF-α and IL-6
production. Conversely, CRP reductions could be the result of an exercise-induced signal (e.g.
mechanotransduction or myokines) that directly enhance endothelial function and inhibit CRP
secretion to the blood stream. A reduction of CRP might express a direct downregulation of
vascular inflammation that helps prevent high blood pressure.
The results of the present study were in agreement with those of Lamina et al. [249] who
reported a CRP reduction after 8 weeks of cycling training at moderate intensity in individuals
with high blood pressure. Interestingly, baseline CRP levels differed between studies. While
Lamina et al. study reported a baseline mean CRP value below 1 mg/L, which is considered to be
in the non-inflammatory range, the present study showed a baseline mean CRP was above 3
mg/L (Table 13), which is categorized as high risk for the development of cardiovascular events
[382,383]. These results confirm that exercise can be employed as an anti-inflammatory strategy
for individuals with high blood pressure.

5.3.3. Oxidative Stress
Oxidative stress is another feature associated with the pathophysiology of high blood
pressure [8,82,83]. In the present study, no changes were observed in oxidative stress status as
observed by the measurements of 8-isoprostane, SOD, and TAC in the plasma of individuals
with elevated blood pressure or stage 1 hypertension after 6 weeks of boxing training (Table 13).
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These findings were incongruent with previous studies. Feairheller et al. [252] reported an
increase in plasma TAC (~9%) and urinary 8-isoprostane (~31%) after 24 weeks of endurance
training at 70%VO2max in individuals with high blood pressure. Beck et al. [246] reported a
reduction in plasma 8-isoprostane (~43%) and an increase in plasma TAC (~43%) after 8 weeks
of resistance training and a reduction in plasma 8-isoprostane (~40%) and an increase in plasma
TAC (~42%) after 8 weeks of endurance training in individuals with elevated blood pressure and
stage 1 hypertension. Lastly, Dantas et al. [253] reported an increase in plasma TAC (~12%)
after 12 weeks of resistance training in elderly women with high blood pressure. Differences in
the oxidative stress responses between the present study and previous studies may be explained
by the length of each exercise program. The present study involved only 6 weeks of training
while the other studies lasted from 8 to 24 weeks.

5.4. Blood Flow Characterization
Physically active individuals have a reduced cardiovascular risk compared to those that
are physically inactive. More than 50% of the cardiovascular benefits of physical activity are not
yet explained by the reduction of classic CVD risk factors (e.g. high blood pressure, obesity, and
dyslipidemia), meaning that other underlying physiological mechanisms may be involved in the
prevention of CVD [21]. One such physiological mechanism thought to contribute to the
prevention of CVD is the mechanical effect of pulsatile blood flow on the vascular wall during
exercise [23,384]. Exercise-induced blood flow regulates vascular homeostasis through cellular
mechanotransduction pathways [62]. Importantly, this regulation is vessel-specific and is
dependent on blood flow characteristics [21,63,64].
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The present study is the first one to characterize blood flow in the common carotid artery
according to its directionality, ESS magnitude, and blood flow pattern during boxing training in
individuals with elevated blood pressure or stage 1 hypertension. Additionally, to the best of our
knowledge, the present study is the first one to analyze blood flow in the carotid artery during an
exercise modality different to cycling or walking [384-389]. In the present study, we
demonstrated that blood flow characteristics in the common carotid artery change from resting to
boxing training conditions. First, both anterograde and retrograde ESS magnitudes increased in
an intensity-dependent manner during exercise. Second, blood flow directionality changed from
solely anterograde at rest to anterograde and retrograde during exercise (Figure 18). Third,
turbulent blood flow was the only pattern observed for anterograde blood flow during exercise,
while laminar blood flow and a transition from laminar to turbulent blood flow were observed at
60% and 95% VO2max for retrograde blood flow, respectively (Figure 19).
Findings described within the present study are similar to those of Liu et al. [384] and
modeled by Wang et al. [390] who reported an increase from baseline in both anterograde and
retrograde ESS in the right common carotid artery during cycling in healthy individuals.
Additionally, Wang et al. reported that ESS increased in an intensity-manner. Similarly, Coovert
et al. [391] reported an increase in anterograde and retrograde shear rate, an ESS surrogate, in the
brachial artery during cycling that were dependent on the intensity of the activity in healthy
individuals. Several in vitro studies, simulating exercise conditions, have shown beneficial
adaptations in endothelial cells exposed to incremental ESS (e.g. eNOS upregulation)
[34,271,273,392]. However, a recent in vitro experiment showed that moderate-intensity ESS
induced higher intracellular NO levels compared to high-intensity ESS [390]. These findings
suggest that vascular adaptations may vary according to the exercise dose.
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In the present study, turbulent blood flow was the predominant blood flow pattern
observed during boxing training at both 60% and 95%VO2max (Figure 19). Similar to the
findings of the present study, Gurovich & Braith [68] reported the presence of anterograde
turbulent blood flow in the brachial and femoral arteries during cycling and resistance training in
healthy individuals when the intensity was at 40% or above their maximal exercise capacity for
each type of activity. Additionally, they also reported a transition from laminar to turbulent
retrograde blood flow in the brachial and femoral arteries when the exercise intensity was at 40%
or above, except for the femoral artery during resistance training where a laminar retrograde
pattern was observed. Moreover, we recently reported the association of hyperemic turbulent
blood flow to peak brachial artery dilation during FMD, which is an endothelium-dependent test
[369]. These findings suggest that turbulent blood flow may be also favorable to maintain
vascular homeostasis.
Altogether, the present study confirms that ESS increased during boxing training which
may partially explain the improvements in cardiovascular health observed in individuals with
elevated blood pressure or stage 1 hypertension after 6 weeks of boxing training.

5.5. Limitations and Future Research
The present study was not without limitations. First, only young adults (<35 years old)
participated in this study, which may limit the generalization of the present results to only young
individuals with elevated blood pressure or stage 1 hypertension. Second, a dietary record was
not employed to ensure that a low-nitrate diet was followed prior blood collection, which could
have affected the results of some biomarkers. Third, some feasibility outcomes regarding the
boxing training intervention were not explored in the present study such as enjoyment, exercise
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tolerance, feelings, and intention to participate [393], which could have been valuable
information for the planning of future studies that would involve this type of training. Fourth, the
DXA scan did not include specific sites (e.g. distal radius) to measure bone changes following
the intervention, which could have reduced the accuracy to detect bone remodeling due to boxing
training. Lastly, structural adaptations in muscular arteries may be better represented by the
conduit dilator capacity rather than the artery diameter, which was not measured in the present
study.
Future boxing training studies in individuals with elevated blood pressure or stage 1
hypertension should include an elderly population or be part of a community-based program to
determine if the results of the present study can be generalized. Finally, the in vivo blood flow
characteristics obtained acutely during boxing training may be employed in future in vitro
studies with human carotid endothelial cells to determine the best training protocol to upregulate
or downregulate genes involved with vascular homeostasis.

5.6. Conclusions
In conclusion, the present study demonstrated that a 6-week, 3 days per week, polarized
boxing training program successfully reduced SBP, DBP, cSBP, and resting heart rate, while
improving cardiorespiratory fitness, vascular health, and quality of life in individuals with
elevated blood pressure or stage 1 hypertension. These effects may be explained, in part, to an
increase in ESS during exercise, which can reverse some pathological pathways involved with
high blood pressure such as endothelial dysfunction, NO bioavailability, peripheral vascular
resistance, and inflammation. Further, boxing training could be recommended as a nontraditional
exercise alternative in the management of high blood pressure.
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APPENDIX A
Boxing Training Program
Week 1
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 3, 4, 3-b, 4-b (Mitt)

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 2 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm
1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 5, 6 (Mitt)

3

Min
HR

2) 95%  ____ bpm

1

2

3

Min
HR

2

3

Min
HR

2

3

Min
HR

2

2

3

1

2

3

1-b, 2-b, 1, 2, 1-b, 2-b (Heavy Bag)

1, 2, 3, 4, 1, 2. Step (Heavy Bag)
1

1

1, 2, 1, 2, 1, 2. Duck (Heavy Bag)

5) 50%  ____ bpm

Min
HR

3

9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
1

2

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)

4) 95%  ____ bpm

Min
HR

1

8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

3

3-b, 4-b, 3-b, 4-b, 5, 6 (Mitt)

3) 95%  ____ bpm

Min
HR

2

7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, Duck, Duck, 3-b, 4-b (Mitt)

3-b, 4-b, 3-b, 4-b, 1, 2 (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

5, 6, 5, 6, 5, 6. Step (Heavy Bag)

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 1, 2, 1, 1, 2. Step (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)

3-b, 4-b, 3-b, 4-b, 3-b, 4-b (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Week 2
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 3, 4, 3-b, 4-b. Step (Mitt)

1, 2, 3, 4, 3-b, 4-b (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, Duck, Duck, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 2 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 3-b, 4-b. (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

1, 2, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Week 3
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 3, 4, 3-b, 4-b (Mitt)

1, 2, 2, 1, 2, 2 (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

3-b, 4-b, 1, 2, 1, 2 (Heavy Bag)

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 2 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 5, 6, 5, 6 (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, Duck, Duck, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4. Step (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2. Step (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min

188

Week 4
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 5, 6, 3-b, 4-b (Mitt)

1, 1, 2, 1, 1, 2. Step (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

1-b, 2-b, 1, 2, 1, 2. Step (Heavy Bag)

3-b, 4-b, 3, 4, 1, 2. Step (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

1, 2, 5, 6, 3-b, 4-b (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 2 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 2, 3, 4, 1, 2. Step (Heavy Bag)
Min
HR

1

2

5, 6, 5, 6, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 1, 2, 3, 4 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4. Step (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 1, 2, 3, 4. Step (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2. Step (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4. Step (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2. Step (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2. Step (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Week 5
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 3, 4, 3-b, 4-b (Mitt)

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 2 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Week 6
Day 1 (

/

/

)
6) 50%  ____ bpm

1) 50%  ____ bpm

1, 2, 3, 4, 3-b, 4-b (Mitt)

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

Min
HR

3

2

3

1

2

3

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
1

2

10) 50%  ____ bpm

5) 50%  ____ bpm

Min
HR

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5, 6, 5, 6, 5, 6 (Mitt)
1

3

9) 50%  ____ bpm

4) 95%  ____ bpm

Min
HR

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

1

8) 50%  ____ bpm

3) 95%  ____ bpm

Min
HR

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

1, 2, 1, 2, 1, 2 (Heavy Bag)
1

2

7) 50%  ____ bpm

2) 95%  ____ bpm

Min
HR

1

Min
HR

3

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min

195

Day 2 (

/

/

)

1) 50%  ____ bpm
6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

1

2

3

2) 95%  ____ bpm
7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

2

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3

Min
HR

1

2

3

3) 95%  ____ bpm
8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
Min
HR

1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

4) 95%  ____ bpm
9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
Min
HR

1

2

1, 2, 1, 2, 3, 4 (Heavy Bag)

3

Min
HR

1

2

3

5) 50%  ____ bpm
10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
Min
HR

1

2

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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Day 3 (

/

/

)

1) 50%  ____ bpm

6) 50%  ____ bpm

1, 1, 2, 1, 1, 2 (Heavy Bag)
Min
HR

1

2

1, 2, 3, 4, 3-b, 4-b (Mitt)

3

Min
HR

2) 95%  ____ bpm

1

2

3

Min
HR

2

3

Min
HR

2

3

Min
HR

2

2

3

1

2

3

10) 50%  ____ bpm

3-b, 4-b, 3, 4, 1, 2 (Heavy Bag)
1

1

1, 2, 1, 2, 3, 4 (Heavy Bag)

5) 50%  ____ bpm

Min
HR

3

9) 50%  ____ bpm

5, 6, 5, 6, 5, 6 (Mitt)
1

2

3-b, 3, 4-b, 4, 1, 2 (Heavy Bag)

4) 95%  ____ bpm

Min
HR

1

8) 50%  ____ bpm

3, 4, 3, 4, 3, 4 (Heavy Bag)
1

3

3-b, 4-b, 3-b, 4-b, 1, 2 (Mitt)

3) 95%  ____ bpm

Min
HR

2

7) 50%  ____ bpm

1, 2, 1, 2, 1, 2 (Heavy Bag)
Min
HR

1

1-b, 2-b, 1, 2, 1, 2 (Heavy Bag)

3

Min
HR

1

2

3

1=Jab, 2=Straight, 3=Left hook, 4=Right Hook, 5=Left Uppercut, 6=Right Uppercut. b=body
Rounds = 3 min; Rest = 1 min
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APPENDIX B
14.0

C-Reactive Protein (mg/L)

12.0

Δ = -1.5
η2p = 0.239

10.0
8.0
6.0
4.0
2.0
0.0

Pre

Post

Pre

Boxing

Post

Control

Figure 22. CRP changes following 6 weeks of boxing training in individuals with elevated blood
pressure or stage 1 hypertension. * p < 0.05.
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